P.4.001 Phenomenology and 24 month treatment outcome of pediatric bipolar disorder (Englisch)
- Neue Suche nach: Carucci, S.
- Neue Suche nach: Atzori, P.
- Neue Suche nach: Balia, C.
- Neue Suche nach: Danjou, F.
- Neue Suche nach: Zuddas, A.
- Neue Suche nach: Carucci, S.
- Neue Suche nach: Atzori, P.
- Neue Suche nach: Balia, C.
- Neue Suche nach: Danjou, F.
- Neue Suche nach: Zuddas, A.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
20
;
S90-S91
;
2010
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P.4.001 Phenomenology and 24 month treatment outcome of pediatric bipolar disorder
-
Beteiligte:Carucci, S. ( Autor:in ) / Atzori, P. ( Autor:in ) / Balia, C. ( Autor:in ) / Danjou, F. ( Autor:in ) / Zuddas, A. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 20 ; S90-S91
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2010
-
Format / Umfang:S90-S91
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 20
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant actionLucassen, P. J. / Meerlo, P. / Naylor, A. S. / van Dam, A. M. / Dayer, A. G. / Fuchs, E. / Oomen, C. A. / Czeh, B. et al. | 2010
- 18
-
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controlsMoreno, F. A. / Parkinson, D. / Palmer, C. / Castro, W. L. / Misiaszek, J. / El Khoury, A. / Mathe, A. A. / Wright, R. / Delgado, P. L. et al. | 2010
- 25
-
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult ratsSpano, M. S. / Fadda, P. / Frau, R. / Fattore, L. / Fratta, W. et al. | 2010
- 37
-
Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in ratsNikiforuk, A. / GoBembiowska, K. / Popik, P. et al. | 2010
- 49
-
The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: Role of PEA-15 as a FADD-ERK binding partner in striatal plasticityRamos-Miguel, A. / Esteban, S. / Garcia-Sevilla, J. A. et al. | 2010
- 65
-
HTR2A gene variation is involved in antidepressant treatment responseLucae, S. / Ising, M. / Horstmann, S. / Baune, B. T. / Arolt, V. / Muller-Myhsok, B. / Holsboer, F. / Domschke, K. et al. | 2010
- 69
-
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A reviewCrunelle, C. L. / Miller, M. L. / Booij, J. / van den Brink, W. et al. | 2010
- 80
-
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorderTauscher, J. / Kielbasa, W. / Iyengar, S. / Vandenhende, F. / Peng, X. / Mozley, D. / Gehlert, D. R. / Marek, G. et al. | 2010
- 88
-
Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorderHernandez, M. E. / Martinez-Fong, D. / Perez-Tapia, M. / Estrada-Garcia, I. / Estrada-Parra, S. / Pavon, L. et al. | 2010
- 96
-
A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteomeSzeg@?, E. M. / Janaky, T. / Szabo, Z. / Csorba, A. / Kompagne, H. / Muller, G. / Levay, G. / Simor, A. / Juhasz, G. / Kekesi, K. A. et al. | 2010
- 112
-
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142Sink, K. S. / Segovia, K. N. / Sink, J. / Randall, P. A. / Collins, L. E. / Correa, M. / Markus, E. J. / Vemuri, V. K. / Makriyannis, A. / Salamone, J. D. et al. | 2010
- 123
-
Effects of escitalopram on stress-related relapses in women with multiple sclerosis: An open-label, randomized, controlled, one-year follow-up studyMitsonis, C. I. / Zervas, I. M. / Potagas, C. M. / Mitropoulos, P. A. / Dimopoulos, N. P. / Sfagos, C. A. / Papadimitriou, G. N. / Vassilopoulos, D. C. et al. | 2010
- 132
-
Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scanRizos, E. N. / Chatziioannou, S. / Douzenis, A. / Siafakas, N. / Katsantoni, E. / Nikolaidou, P. / Papathanasiou, M. / Lykouras, L. et al. | 2010
- 137
-
Erratum to Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects [Eur. Neuropsychopharmacol. 19 (2009) 718 725]Kato, M. / Okugawa, G. / Wakeno, M. / Takekita, Y. / Nonen, S. / Tetsuo, S. / Nishida, K. / Azuma, J. / Kinoshita, T. / Serretti, A. et al. | 2010
- 139
-
The risk of death among adult participants in trials of antipsychotic drugs in schizophreniaIsaac, M. / Koch, A. et al. | 2010
- 146
-
Late potentials in the signal-averaged electrocardiogram in schizophrenia patients maintained on antipsychotic agentsNahshoni, E. / Strasberg, B. / Imbar, S. / Rotem, O. / Gur, S. / Hermesh, H. / Weizman, A. et al. | 2010
- 153
-
Chronic effects of cannabis use on the human reward system: An fMRI studyvan Hell, H. H. / Vink, M. / Ossewaarde, L. / Jager, G. / Kahn, R. S. / Ramsey, N. F. et al. | 2010
- 164
-
Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in miceLin, E. J. / Lin, S. / Aljanova, A. / During, M. J. / Herzog, H. et al. | 2010
- 176
-
The development- and phencyclidine-regulated induction of synapse-associated protein-97 gene in the rat neocortexHiraoka, S. / Kajii, Y. / Kuroda, Y. / Umino, A. / Nishikawa, T. et al. | 2010
- 187
-
Effects of repeated risperidone exposure on serotonin receptor subtypes in developing ratsChoi, Y. K. / Moran-Gates, T. / Gardner, M. P. / Tarazi, F. I. et al. | 2010
- 195
-
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in miceSasso, O. / La Rana, G. / Vitiello, S. / Russo, R. / D'Agostino, G. / Iacono, A. / Russo, E. / Citraro, R. / Cuzzocrea, S. / Piazza, P. V. et al. | 2010
- 207
-
NMDA NR2B subtype-selective receptor antagonists fail to antagonize electrically-precipitated seizures and elicit popping in miceBurket, J. A. / Mastropaolo, J. / Rosse, R. B. / Katz, E. U. / Deutsch, S. I. et al. | 2010
- 211
-
The effect of chronic antipsychotic drug administration on nitric oxide synthase activity and gene expression in rat penile tissuesZhang, X. R. / Zhang, Z. J. / Jenkins, T. A. / Cheng, W. R. / Reynolds, G. P. et al. | 2010
- 218
-
(+)-UH 232, a partial agonist of the D3 dopamine receptors, attenuates cognitive effects of angiotensin IV and des-Phe^6-angiotensin IV in ratsBraszko, J. J. et al. | 2010
- 226
-
Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increasedVan Ruitenbeek, P. / Vermeeren, A. / Riedel, W. J. et al. | 2010
- 236
-
The multifaceted effects of oral administration of methylphenidate in juvenile rats: Anxiety, activity, and attentionZhu, N. / Weedon, J. / Dow-Edwards, D. L. et al. | 2010
- 245
-
Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholicsLehtonen, M. / Storvik, M. / Tupala, E. / Hyytia, P. / Tiihonen, J. / Callaway, J. C. et al. | 2010
- 253
-
Mapping the brain pathways of traumatic memory: Inactivation of protein kinase M zeta in different brain regions disrupts traumatic memory processes and attenuates traumatic stress responses in ratsCohen, H. / Kozlovsky, N. / Matar, M. A. / Kaplan, Z. / Zohar, J. et al. | 2010
- 272
-
Deletion variant of +/-2b-adrenergic receptor gene moderates the effect of COMT val^1^5^8met polymorphism on episodic memory performanceGibbs, A. A. / Naudts, K. H. / Azevedo, R. T. / David, A. S. et al. | 2010
- 276
-
How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?Hamann, J. / Mendel, R. / Heres, S. / Leucht, S. / Kissling, W. et al. | 2010
- 281
-
Does subtle disturbance of neuronal migration contribute to schizophrenia and other neurodevelopmental disorders? Potential genetic mechanisms with possible treatment implicationsDeutsch, S. I. / Burket, J. A. / Katz, E. et al. | 2010
- 288
-
Differential gene expression in a rat model of depression based on persistent differences in exploratory activityAlttoa, A. / Koiv, K. / Hinsley, T. A. / Brass, A. / Harro, J. et al. | 2010
- 301
-
Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depressionDomschke, K. / Dannlowski, U. / Hohoff, C. / Ohrmann, P. / Bauer, J. / Kugel, H. / Zwanzger, P. / Heindel, W. / Deckert, J. / Arolt, V. et al. | 2010
- 310
-
Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)for, t. E. / Gaebel, W. / Riesbeck, M. / von Wilmsdorff, M. / Burns, T. / Derks, E. M. / Kahn, R. S. / Rossler, W. / Fleischhacker, W. W. et al. | 2010
- 317
-
Chromosomal mapping of excessive physical activity in mice in response to a restricted feeding scheduleGelegen, C. / Pjetri, E. / Campbell, I. C. / Collier, D. A. / Oppelaar, H. / Kas, M. J. et al. | 2010
- 327
-
No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatmentBukh, J. D. / Bock, C. / Vinberg, M. / Werge, T. / Gether, U. / Kessing, L. V. et al. | 2010
- 336
-
Region- and phase-dependent effects of 5-HT1A and 5-HT2C receptor activation on adult neurogenesisSoumier, A. / Banasr, M. / Goff, L. K. / Daszuta, A. et al. | 2010
- 346
-
Outcomes of 1014 naturalistically treated inpatients with major depressive episodeSeemuller, F. / Riedel, M. / Obermeier, M. / Bauer, M. / Adli, M. / Kronmuller, K. / Holsboer, F. / Brieger, P. / Laux, G. / Bender, W. et al. | 2010
- 357
-
The involvement of GSK3sz in bipolar disorder: Integrating evidence from multiple types of genetic studiesLuykx, J. J. / Boks, M. P. / Terwindt, A. P. / Bakker, S. / Kahn, R. S. / Ophoff, R. A. et al. | 2010
- 369
-
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB1 knockout miceBura, S. / Burokas, A. / Martin-Garcia, E. / Maldonado, R. et al. | 2010
- 379
-
Antidepressants, but not antipsychotics, modulate GR function in human whole blood: An insight into molecular mechanismsCarvalho, L. A. / Garner, B. A. / Dew, T. / Fazakerley, H. / Pariante, C. M. et al. | 2010
- 388
-
Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: Modulation by midazolamBignante, E. A. / Paglini, G. / Molina, V. A. et al. | 2010
- 398
-
Cortical thickness and voxel-based morphometry in depressed elderlyKoolschijn, P. C. / van Haren, N. E. / Schnack, H. G. / Janssen, J. / Hulshoff Pol, H. E. / Kahn, R. S. et al. | 2010
- 405
-
Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline systemXu, Y. / Wang, Z. / You, W. / Zhang, X. / Li, S. / Barish, P. A. / Vernon, M. M. / Du, X. / Li, G. / Pan, J. et al. | 2010
- 414
-
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patientsLennertz, L. / Wagner, M. / Frommann, I. / Schulze-Rauschenbach, S. / Schuhmacher, A. / Kuhn, K. U. / Pukrop, R. / Klosterkotter, J. / Wolwer, W. / Gaebel, W. et al. | 2010
- 421
-
The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in ratsWeber, M. / Chang, W. L. / Breier, M. R. / Yang, A. / Millan, M. J. / Swerdlow, N. R. et al. | 2010
- 426
-
Manifesto for a European Anxiety Disorders Research NetworkBaldwin, D. S. / Allgulander, C. / Altamura, A. C. / Angst, J. / Bandelow, B. / den Boer, J. / Boyer, P. / Davies, S. / dell'Osso, B. / Eriksson, E. et al. | 2010
- 433
-
Antidepressants in healthy subjects: What are the psychotropic/psychological effects?Serretti, A. / Calati, R. / Goracci, A. / Di Simplicio, M. / Castrogiovanni, P. / De Ronchi, D. et al. | 2010
- 454
-
Cigarette smoking and progressive brain volume loss in schizophreniaVan Haren, N. E. / Koolschijn, P. C. / Cahn, W. / Schnack, H. G. / Hulshoff Pol, H. E. / Kahn, R. S. et al. | 2010
- 459
-
The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatmentsBares, M. / Brunovsky, M. / Novak, T. / Kopecek, M. / Stopkova, P. / Sos, P. / Krajca, V. / Hoschl, C. et al. | 2010
- 467
-
Retrograde facilitation of verbal memory by trihexyphenidyl in healthy elderly with and without the APOE e4 allelePomara, N. / Yi, L. / Belzer, K. / Facelle, T. M. / Willoughby, L. M. / Sidtis, J. J. et al. | 2010
- 473
-
Electrocortical effects of acute tryptophan depletion on emotive facial processing in depression-prone individualsJaworska, N. / Thompson, A. / Shah, D. / Fisher, D. / Ilivitsky, V. / Knott, V. et al. | 2010
- 487
-
The selective 5-HT1A receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake ratKehr, J. / Hu, X. J. / Yoshitake, T. / Wang, F. H. / Osborne, P. / Stenfors, C. / Ogren, S. O. et al. | 2010
- 501
-
The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitizationVelazquez-Sanchez, C. / Ferragud, A. / Murga, J. / Carda, M. / Canales, J. J. et al. | 2010
- 509
-
Development of morphine-induced tolerance and withdrawal: Involvement of the clock gene mPer2Perreau-Lenz, S. / Sanchis-Segura, C. / Leonardi-Essmann, F. / Schneider, M. / Spanagel, R. et al. | 2010
- 519
-
Exploring the brain network: A review on resting-state fMRI functional connectivityvan den Heuvel, M. P. / Hulshoff Pol, H. E. et al. | 2010
- 535
-
Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorderZou, Y. F. / Ye, D. Q. / Feng, X. L. / Su, H. / Pan, F. M. / Liao, F. F. et al. | 2010
- 545
-
Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to ratsGershkovich, P. / Sivak, O. / Sharma, A. / Barr, A. M. / Procyshyn, R. / Wasan, K. M. et al. | 2010
- 553
-
Impaired off-line memory consolidation in depressionDresler, M. / Kluge, M. / Genzel, L. / Schussler, P. / Steiger, A. et al. | 2010
- 562
-
Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: A meta-analysisTedeschini, E. / Fava, M. / Goodness, T. M. / Papakostas, G. I. et al. | 2010
- 568
-
Increased voluntary ethanol consumption and c-Fos expression in selected brain areas induced by fear memory retrieval in ethanol withdrawn ratsBertotto, M. E. / Bussolino, D. F. / Molina, V. A. / Martijena, I. D. et al. | 2010
- 582
-
An in vivo pharmacological evaluation of pardoprunox (SLV308) - A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's diseaseJones, C. A. / Johnston, L. C. / Jackson, M. J. / Smith, L. A. / van Scharrenburg, G. / Rose, S. / Jenner, P. G. / McCreary, A. C. et al. | 2010
- 594
-
Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor VenlafaxineChristoph, M. / Ebner, B. / Stolte, D. / Ibrahim, K. / Kolschmann, S. / Strasser, R. H. / Schon, S. et al. | 2010
- 599
-
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetineMillan, M. J. / Dekeyne, A. / Gobert, A. / Mannoury la Cour, C. / Brocco, M. / Rivet, J. M. / Di Cara, B. / Lejeune, F. / Cremers, T. I. / Flik, G. et al. | 2010
- 622
-
Activity-based anorexia in C57/BL6 mice: Effects of the phytocannabinoid, ^9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2Lewis, D. Y. / Brett, R. R. et al. | 2010
- 632
-
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoproteinKarlsson, L. / Schmitt, U. / Josefsson, M. / Carlsson, B. / Ahlner, J. / Bengtsson, F. / Kugelberg, F. C. / Hiemke, C. et al. | 2010
- 641
-
F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonistsDepoortere, R. / Auclair, A. L. / Bardin, L. / Colpaert, F. C. / Vacher, B. / Newman-Tancredi, A. et al. | 2010
- 655
-
Seasonality and winter-type seasonal depression are associated with the rs731779 polymorphism of the serotonin-2A receptor geneMolnar, E. / Lazary, J. / Benko, A. / Gonda, X. / Pap, D. / Mekli, K. / Juhasz, G. / Kovacs, G. / Kurimay, T. / Rihmer, Z. et al. | 2010
- 663
-
Mixture regression analysis on age at onset in Bipolar Disorder patients: Investigation of the role of serotonergic genesManchia, M. / Zai, C. C. / Squassina, A. / Vincent, J. B. / De Luca, V. / Kennedy, J. L. et al. | 2010
- 671
-
The economic impact of depression: Resistance or severity?Fostick, L. / Silberman, A. / Beckman, M. / Spivak, B. / Amital, D. et al. | 2010
- 676
-
First episode drug-naive major depressive disorder with panic disorder: Gray matter deficits in limbic and default network structuresLai, C. H. / Hsu, Y. Y. / Wu, Y. T. et al. | 2010
- 683
-
Levodopa and 3-OMD levels in Parkinson patients treated with DuodopaAntonini, A. / Bondiolotti, G. / Natuzzi, F. / Bareggi, S. R. et al. | 2010
- 688
-
Association study of the GSK-3B gene with tardive dyskinesia in European CaucasiansSouza, R. P. / Remington, G. / Chowdhury, N. I. / Lau, M. K. / Voineskos, A. N. / Lieberman, J. A. / Meltzer, H. Y. / Kennedy, J. L. et al. | 2010
- 695
-
Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamineZhornitsky, S. / Potvin, S. / Stip, E. / Rompre, P. P. et al. | 2010
- 704
-
The b3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changesTamburella, A. / Micale, V. / Leggio, G. M. / Drago, F. et al. | 2010
- 714
-
The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHDSimchon, Y. / Weizman, A. / Rehavi, M. et al. | 2010
- 721
-
Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patientsGarcia-Sevilla, J. A. / Alvaro-Bartolome, M. / Diez-Alarcia, R. / Ramos-Miguel, A. / Puigdemont, D. / Perez, V. / Alvarez, E. / Meana, J. J. et al. | 2010
- 731
-
The a2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsSemenova, S. / Markou, A. et al. | 2010
- 747
-
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depressionKasper, S. / Caraci, F. / Forti, B. / Drago, F. / Aguglia, E. et al. | 2010
- 766
-
Pathological gambling: Relation of skin conductance response to dopaminergic neurotransmission and sensation-seekingPeterson, E. / Moller, A. / Doudet, D. J. / Bailey, C. J. / Hansen, K. V. / Rodell, A. / Linnet, J. / Gjedde, A. et al. | 2010
- 776
-
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)El Mallakh, R. S. / Vieta, E. / Rollin, L. / Marcus, R. / Carson, W. H. / McQuade, R. et al. | 2010
- 784
-
Dopaminergic modulation of the default mode network in Parkinson's diseaseDelaveau, P. / Salgado-Pineda, P. / Fossati, P. / Witjas, T. / Azulay, J. P. / Blin, O. et al. | 2010
- 793
-
Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming testZomkowski, A. D. / Engel, D. / Gabilan, N. H. / Rodrigues, A. L. et al. | 2010
- 802
-
Exposure of mice to long-light: A new animal model to study depressionBecker, A. / Bilkei-Gorzo, A. / Michel, K. / Zimmer, A. et al. | 2010
- 813
-
In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by a2-adrenoceptor antagonismOrtega, J. E. / Fernandez-Pastor, B. / Callado, L. F. / Meana, J. J. et al. | 2010
- 823
-
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependenceGrant, J. E. / Odlaug, B. L. / Kim, S. W. et al. | 2010
- S1
-
S.1.02 The neuropharmacology of impulsive behaviour with focus on translational aspectsPattij, T. / Schoffelmeer, A. N. et al. | 2010
- S2
-
P.1.001 Chronic clozapine treatment reduces reelin expression in the rat prefrontal cortexBasu, A. / Sugden, K. / Tandon, K. / Fernandes, C. / Tsapakis, E. M. / Stephenson, J. / Aitchison, K. J. et al. | 2010
- S3
-
P.1.002 The histamine site of the NMDA receptor: a new target to increase NMDA receptor functionBurban, A. / Faucard, R. / Armand, V. / Bayard, C. / Vorobjev, V. / Arrang, J. M. et al. | 2010
- S4
-
P.1.003 Clinical and genetic predictors of worsening after aripiprazole switch: results from a randomised open studyChiesa, A. / Pae, C. U. / Mandelli, L. / De Ronchi, D. / Serretti, A. et al. | 2010
- S6
-
P.1.006 Neurogenic and chronic behavioural effects of fluoxetine are attenuated in p11 KO miceEgeland, M. / Warner-Schmidt, J. / Greengard, P. / Svenningsson, P. et al. | 2010
- S7
-
P.1.007 Levels of activators of cyclin-dependent protein kinase 5 (Cdk5) p25 and p35 in Alzheimers diseaseEngmann, O. / Hortobagyi, T. / Thompson, A. / Giese, K. P. et al. | 2010
- S8
-
P.1.008 Evaluation of the endocannabinoid system in post-mortem human prefrontal cortex of alcoholic subjectsErdozain, A. M. / Alexander, S. P. / Kendall, D. A. / Valdizan, E. M. / Meana, J. J. / Callado, L. F. et al. | 2010
- S9
-
P.1.009 Mice with decreased vesicular glutamate transporter VGLUT1 levels show an altered presynaptic 5-HT functionGarcia-Garcia, A. L. / Elizalde, N. / Venzala, E. / Del Rio, J. / Lanfumey, L. / Tordera, R. M. et al. | 2010
- S10
-
P.1.010 Repeated brain stimulation affects markers for neuroplasticity: differential outcomes in anaesthetized and awake animalsGersner, R. / Kravetz, E. / Levit, O. / Zangen, A. et al. | 2010
- S11
-
P.1.011 ADRA2B genotype moderates the effect of catechol-O-methyltransferase genotype on episodic memory performanceGibbs, A. A. / Naudts, K. / Azevedo, R. / David, A. S. et al. | 2010
- S13
-
P.1.014 Identification of a mouse febrile seizure susceptibility geneHessel, E. V. / Kas, M. J. / van Lith, H. A. / Wolterink-Donselaar, I. G. / de Wit, M. / de Graan, P. N. et al. | 2010
- S14
-
P.1.015 Long-term fluoxetine reverses alpha2-adrenoceptors desensitization induced by chronic corticosterone treatmentHorrillo, I. / Ortega, J. E. / Meana, J. J. et al. | 2010
- S15
-
P.1.016 Association of the adrenergic receptor alpha1b with antidepressant treatment in the MARS studyHorstmann, S. / Menke, A. / Straub, V. / Hennings, J. / Lucae, S. / Wollweber, S. / Binder, E. B. et al. | 2010
- S17
-
P.1.020 A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patientsLennertz, L. / Mossner, R. et al. | 2010
- S18
-
P.1.021 Low CD38 gene expression in lymphoblastoid cells and in haplotypes is associated with autism spectrum disordersLerer, E. / Yirmiya, N. / Salomon, S. / Ebstein, R. P. et al. | 2010
- S19
-
P.1.022 Amyloid aggregation is critical for the interaction with neuronal nicotinic acetylcholine receptors (nAChRs) - implications for neuroprotection in Alzheimers diseaseLilja, A. M. / Porras, O. / Storelli, E. / Nordberg, A. / Marutle, A. et al. | 2010
- S20
-
P.1.023 Effect of antidepressants on lipopolysaccharide-induced interleukin-1b levels in brain and plasma of ratsPrymus, A. / Obuchowicz, E. / Bielecka, A. / Drzyzga, L. / Kot, M. / Daniel, W. A. / Krupka-Matuszczyk, I. et al. | 2010
- S21
-
P.1.024 Depressive disorder moderates the effect of fat mass and obesity-associated gene (FTO) on body mass index (BMI)Rivera, M. / Cohen-Woods, S. / Breen, G. / Butler, A. W. / Korszun, A. / Lewis, C. M. / Uher, R. / Craig, I. / Farmer, A. E. / McGuffin, P. et al. | 2010
- S23
-
P.1.027 Cued but not contextual fear conditioning impairment in the NMDA receptor subunit NR1-DbhCre transgenic miceSolecki, W. / Szklarczyk, K. / Kubik, J. / Sikora, M. / Rodriquez Parkitna, J. / Schutz, G. / Przewlocki, R. et al. | 2010
- S24
-
P.1.028 Altered functional connectivity of the amygdala in social anxiety disorderStein, P. / Weissenbacher, A. / Hahn, A. / Gerstl, F. / Windischberger, C. / Moser, E. / Kasper, S. / Lanzenberger, R. et al. | 2010
- S25
-
P.1.029 Vagus nerve stimulation induces cell proliferation and changes in neuronal morphology in the rat hippocampusUtzeri, C. / Biggio, F. / Olla, P. / Follesa, P. / Biggio, G. et al. | 2010
- S27
-
P.1.032 Study of the effect of acute stress on glutamate release in prefrontal/frontal cortex of antidepressant treated ratsZagaria, N. / Musazzi, L. / Milanesi, M. / Farisello, P. / Mallei, A. / Baldelli, P. / Racagni, G. / Benfenati, F. / Bonanno, G. / Popoli, M. et al. | 2010
- S29
-
P.2.001 The impact of enhanced endocannabinoid neurotransmission on the food taking behaviour in ratsAdamczyk, P. / McCreary, A. C. / Przegalinski, E. / Filip, M. et al. | 2010
- S30
-
P.2.003 Time dependent changes in dopamine response dynamics after chronic haloperidol treatment: an in-vivo microdialysis studyAmato, D. / Natesan, S. / Kapur, S. / Muller, C. P. et al. | 2010
- S31
-
P.2.004 Altered aggressive behaviour following genetic and pharmacological manipulation of serotonin autoinhibitionAudero, E. / Mlinar, B. / Skachokova, Z. K. / Caprioli, A. / Corradetti, R. / Gross, C. et al. | 2010
- S32
-
P.2.005 Testing the role of serotonin in the appraisal of romantic relationships in healthy adults: implications for depressionBilderbeck, A. C. / McCabe, C. / McGlone, F. / Wakeley, J. / Di Simplicio, M. / Godlewska, B. / Harris, T. / Cowen, P. J. / Rogers, R. D. et al. | 2010
- S33
-
P.2.006 Impulsive choice predicts resistance to extinction of cocaine seeking and enhanced vulnerability to cue-induced relapseBroos, N. / Schoffelmeer, A. N. / Pattij, T. / De Vries, T. J. et al. | 2010
- S34
-
P.2.007 Pergolide attenuates memory impairment and oxidative stress in a 6-hydroxydopamine model of Parkinsons diseaseCiobica, A. / Hritcu, L. / Artenie, V. / Bild, W. / Padurariu, M. et al. | 2010
- S36
-
P.2.010 Memory-enhancing property of a new benzothiadiazine derivative, BB16: behavioural and microdialysis studiesDi Viesti, V. / Carnevale, G. / Zavatti, M. / Zanoli, P. / Cannazza, G. / Braghiroli, D. / Baraldi, M. et al. | 2010
- S37
-
P.2.011 Subchronic administration of phencyclidine reduces social interaction and increases aggressive-like behaviour in miceElvander-Tottie, E. / Tai, F. / Holst, S. / Beraki, S. / Wadenberg, S. / Svenningsson, P. / Ogren, S. O. et al. | 2010
- S38
-
P.2.012 Investigating the role of the endocannabinoid system in a rat model of distraction-induced analgesiaFord, G. K. / Moriarty, O. / Tulley, E. / Mulcahy, A. / Finn, D. P. et al. | 2010
- S40
-
P.2.015 Antiparkinsonian effects of H3 receptor inverse agonists: a behavioural study with ciproxifan in the 6-OHDA rat modelHumbert-Claude, M. / Guilloux, J. P. / Arrang, J. M. et al. | 2010
- S41
-
P.2.016 A possible involvement of opioid degrading enzymes in individual reactivity to acute traumatic stressKavushansky, A. / Klein, E. / Ben-Shachar, D. et al. | 2010
- S42
-
P.2.017 Mice lacking two key phosphorylation sites on the GluR1 subunit exhibit decreased anxiety-like behaviourKiselycznyk, C. / Svenningsson, P. et al. | 2010
- S43
-
P.2.018 Impact of purinergic receptors in prefrontal mediated cognitive and executive functionsKoch, H. / Franke, H. / Krugel, U. et al. | 2010
- S45
-
P.2.021 Attentional bias to smoking related cues. A comparison of daily smokers, social smokers and non-smokersMullings, E. / Munafo, M. et al. | 2010
- S46
-
P.2.022 Exposure to antidepressant medications is not related to suicide attempts in adult depressed patientsOlmer, A. / Iancu, I. et al. | 2010
- S47
-
P.2.023 Glycine transporter 1 disruption restricted to the nucleus accumbens is sufficient to enhance latent inhibitionPeleg-Raibstein, D. / Paterna, J. C. / Schwendener, S. / Boison, D. / Mohler, H. / Feldon, J. / Yee, B. K. et al. | 2010
- S48
-
P.2.024 Attenuation by paroxetine and D-cycloserine of the deficit in cognitive processes following acute stress: an animal model of PTSDPhilbert, J. / Pichat, P. / Santamaria, R. / Biton, B. / Bergis, O. / Avenet, P. / Griebel, G. et al. | 2010
- S50
-
P.2.027 Is the brain a special compartment with respect to free corticosterone? A dual probe in vivo microdialysis study in ratsQian, X. / Droste, S. K. / Lightman, S. L. / Reul, J. M. / Linthorst, A. C. et al. | 2010
- S51
-
P.2.028 Aversive taste memory augmentation following NMDA receptor antagonist administrationRamirez-Lugo, L. / Wegener, G. / West, M. J. / Morten, S. J. et al. | 2010
- S52
-
P.2.029 The effect of neonatal serotonin depletion on reinforcing potential of psychoactive substances and natural rewardRok-Bujko, P. / Krzascik, P. / Stefanski, R. / Kostowski, W. et al. | 2010
- S53
-
P.2.030 Influence of UFP-101 central infusion on behavioural and cellular effects in a chronic stress model in the ratRuggieri, V. / Vitale, G. / Filaferro, M. / Zucchini, S. / Simonato, M. / Cifani, C. / Massi, M. et al. | 2010
- S54
-
P.2.032 Intranasal administration of arginine vasopressin enhances acute stress response in social encountersShalev, I. / Israel, S. / Uzefovsky, F. / Kaitz, M. / Ebstein, R. P. et al. | 2010
- S55
-
P.2.033 Environmental manipulation influences depression-like behaviour in genotype dependent mannerSikora, M. / Solecki, W. / Kubik, J. / Przewlocki, R. et al. | 2010
- S56
-
P.2.034 Wrong expectations? Expectancy coding of gains and losses in alcohol dependent subjects and pathological gamblersvan Holst, R. J. / Goudriaan, A. E. / Veltman, D. J. / van den Brink, W. et al. | 2010
- S59
-
S.3.01 New uses of MRI in psychiatryRamsey, N. F. et al. | 2010
- S60
-
S.3.02 Mechanisms of placebo and placebo related effects across diseases and treatmentsBenedetti, F. et al. | 2010
- S62
-
P.3.001 Serotonin transporter (SERT) availability in raphe nuclei quantified with PET predicts treatment response to S-citalopram in major depressive disorderAkimova, E. / Lanzenberger, R. / Savli, M. / Hausler, D. / Wadsak, W. / Spindelegger, C. / Moser, U. / Fink, M. / Kletter, K. / Kasper, S. et al. | 2010
- S64
-
P.3.004 Effect of tryptophan depletion and loading on the response to double breath 35% CO2 challenge in healthy volunteersColasanti, A. / Esquivel, G. / den Boer, E. / Horlings, A. / Schruers, K. / Griez, E. J. et al. | 2010
- S65
-
P.3.005 Antidepressant treatment modulates neural responses to self-referential words in subjects with high neuroticismDi Simplicio, M. / Norbury, R. / Harmer, C. J. et al. | 2010
- S66
-
P.3.006 The relationship between 5-HTTLPR polymorphism and hippocampal volumes in medication-free depressed patientsEker, M. C. / Okur, H. / Kitis, O. / Donat-Eker, O. / Ozan, E. / Akarsu, N. / Gonul, A. S. et al. | 2010
- S67
-
P.3.007 Abnormalities in reward prediction error signals in depression and schizophreniaGradin, V. B. / Kumar, P. / Waiter, G. / Ahearn, T. / Reid, I. / Stickle, C. / Milders, M. / Hall, J. / Steele, J. D. et al. | 2010
- S68
-
P.3.008 Acute tryptophan depletion increases cingulate cortex reactivity in recovered depressed patientsHorder, J. / Cowen, P. / Browning, M. / McTavish, S. / Harmer, C. J. et al. | 2010
- S69
-
P.3.009 Effects of naltrexone on amphetamine-induced changes in the brain dopamine systemJayaram-Lindstrom, N. / Haggkvist, J. / Halldin, C. / Schilstrom, B. / Nordstrom, A. L. / Franck, J. et al. | 2010
- S70
-
P.3.010 CYP2D6 and CYP2C19 genotypes predict antidepressant dose in the GENDEP projectKeers, R. / Ingelman-Sundberg, M. / Hauser, J. / Maier, W. / Rietschel, M. / Mors, O. / McGuffin, P. / Farmer, A. E. / Craig, I. W. / Aitchison, K. J. et al. | 2010
- S71
-
P.3.011 Visual information processing abnormalities as biomarker of schizophrenia: an EEG study in schizotypyKoychev, I. / El-Deredy, W. / Haenschel, C. / Deakin, J. F. et al. | 2010
- S72
-
P.3.012 Corticostriatal white matter development is changed in autismLangen, M. / Mandl, R. C. / Pol, H. E. / van Engeland, H. / Durston, S. et al. | 2010
- S73
-
P.3.013 Interaction between alcohol and opioids in opioid-dependent subjectsLees, R. / Williams, T. / Henderson, G. / Hickman, M. / Lingford-Hughes, A. et al. | 2010
- S74
-
P.3.015 Community treatment orders, ethnicity, conditions and psychotropic medication: the first six months (N = 126)Patel, M. X. / Matonhodze, J. / Gilleen, J. / Boydell, J. / Taylor, D. / Szmukler, G. / Lambert, T. J. / David, A. S. et al. | 2010
- S75
-
P.3.016 Temporal lobe grey matter volume in schizophrenia is influenced by glycogen synthase kinase 3-beta activityPoletti, S. / Radaelli, D. / Lorenzi, C. / Smeraldi, E. / Benedetti, F. et al. | 2010
- S76
-
P.3.017 Acute low dose tryptophan depletion in volunteers at high risk for eating disordersPringle, A. / Cooper, M. J. / Browning, M. / Harmer, C. J. et al. | 2010
- S77
-
P.3.018 Mirtazapine reduces neural responses to fearful faces in healthy volunteersRawlings, N. B. / Norbury, R. / Cowen, P. J. / Harmer, C. J. et al. | 2010
- S79
-
P.3.021 Long acting naltrexone implants for heroin dependenceTiurina, A. / Krupitsky, E. / Zvartau, E. / Woody, G. et al. | 2010
- S80
-
P.3.022 Initial antidepressant monotherapy in bipolar depression is associated to more suicide attempts and switch into maniaValenti, M. / Pacchiarotti, I. / Nivoli, A. M. / Murru, A. / Colom, F. / Vieta, E. et al. | 2010
- S84
-
P.3.027 Oxcarbazepine, gabapentin and lamotrigine in treatment of heroin cravingZivkovic, N. / Pavicevic, D. / Djokic, G. et al. | 2010
- S85
-
P.3.028 Somatisation in major depression, genetic association and clinical featuresKlengel, T. / Heck, A. / Pfister, H. / Hennings, J. M. / Menke, A. / Lucae, S. / Holsboer, F. / Ising, M. et al. | 2010
- S87
-
S.4.01 Molecular drug targets for bipolar disordersManji, H. et al. | 2010
- S89
-
S.4.02 Current status and unmet needs of treatment in bipolar disordersYoung, A. et al. | 2010
- S90
-
P.4.001 Phenomenology and 24 month treatment outcome of pediatric bipolar disorderCarucci, S. / Atzori, P. / Balia, C. / Danjou, F. / Zuddas, A. et al. | 2010
- S91
-
P.4.002 Mismatch negativity and executive functions in schizophrenia and bipolar disorderDomjan, N. / Csifcsak, G. / Szendi, I. / Janka, Z. et al. | 2010
- S93
-
P.4.005 Differential response to treatment across countries in a randomized clinical trial in maniaPacchiarotti, I. / Pappdopulos, E. / Mandel, F. / Lombardo, I. / Loebel, A. / Vieta, E. et al. | 2010
- S94
-
P.4.006 Students scoring highly on the mood disorder questionnaire show increased dorsolateral prefrontal cortex (DLPFC) activity to threatening wordsRock, P. L. / Goodwin, G. M. / Harmer, C. J. et al. | 2010
- S95
-
P.4.007 Effects of atypical antipsychotics on neurocognition in euthymic bipolar patientsRosa, A. / Torrent, C. / Martinez-Aran, A. / Daban, C. / Amann, B. / Balanza-Martinez, V. / Bonnin, C. M. / Cruz, N. / Tabares-Seisdedos, R. / Vieta, E. et al. | 2010
- S96
-
P.4.009 Cognitive dysfunction in bipolar patients: association with depressive symptoms and alcohol usevan der Werf-Eldering, M. J. / Burger, H. / Holthausen, E. A. / Aleman, A. / Nolen, W. A. et al. | 2010
- S97
-
P.4.010 Serotonin inhibits field potentials in the medial prefrontal cortexWallace, J. / McQuade, R. / Marston, H. M. / Gartside, S. E. et al. | 2010
- S99
-
Author Index| 2010
- S103
-
Keyword Index| 2010
- S105
-
Heroin-assisted treatment in the Netherlands: History, findings, and international contextBlanken, P. / van den Brink, W. / Hendriks, V. M. / Huijsman, I. A. / Klous, M. G. / Rook, E. J. / Wakelin, J. S. / Barendrecht, C. / Beijnen, J. H. / van Ree, J. M. et al. | 2010
- S161
-
S.01.04 Steroid-monoamine interactions in emotionHurlemann, R. / Onur, O. A. / Kukolja, J. et al. | 2010
- S162
-
S.02.03 Tau toxicity in cell and animal modelsMandelkow, E. M. / Thies, E. / Sydow, A. / Wang, Y. / Biernat, J. / Mandelkow, E. et al. | 2010
- S163
-
S.03.01 The past, present and future role of the dopamine D2 receptor in schizophreniaKapur, S. et al. | 2010
- S164
-
S.03.03 Brain connectivity modulation by novel antipsychotics: an electrophysiological approachSpedding, M. / Sebban, C. / Jay, T. / Schenker, E. / Gacsalyi, I. et al. | 2010
- S165
-
S.04.01 Identification of a mouse febrile seizure susceptibility geneHessel, E. V. / de Wit, M. / Wolterink-Donselaar, I. G. / van Lith, H. A. / Kas, M. J. / de Graan, P. N. et al. | 2010
- S166
-
S.04.04 Stress-induced alterations in hippocampal and amygdalar microRNAs: effects of lithiumOConnor, R. M. / OLeary, O. F. / Dinan, A. / Gokul, A. / Dinan, T. G. / Cryan, J. F. et al. | 2010
- S168
-
S.05.02 Neuronal signaling and epigenetic mechanisms at the cognition-emotion interfaceReul, J. M. et al. | 2010
- S169
-
S.05.04 Glucocorticoids and noradrenaline in severe stress exposure in humansSchelling, G. / Roozendaal, B. / Campolongo, P. / de Quervain, D. et al. | 2010
- S170
-
S.06.04 NGF and BDNF as neuroendocrine factors involved in the response to early life stress and susceptibility to psychopathology: evidence from animal modelsCirulli, F. / Aloe, L. / Francia, N. / Berry, A. / Alleva, E. / Suomi, S. J. et al. | 2010
- S171
-
S.07.02 Cued but not contextual fear conditioning impairment in the NMDA receptor subunit NR1-DbhCre transgenic miceSolecki, W. / Szklarczyk, K. / Kubik, J. / Sikora, M. / Parkitna, J. / Przewlocki, R. et al. | 2010
- S172
-
S.07.04 CYP2D6 genotype predicts antidepressant dose in the GENDEP projectKeers, R. / Ingelman-Sundberg, M. / Hauser, J. / Maier, W. / Rietschel, M. / Mors, O. / McGuffin, P. / Farmer, A. E. / Craig, I. W. / Aitchison, K. J. et al. | 2010
- S174
-
S.08.01 Involvement of hippocampal neurogenesis in the control of the HPA axis: evidence from animal models of affective diseaseBelzung, C. / Surget, A. / Tanti, A. / Laugeray, A. / Rainer, Q. / Griebel, G. / Hen, R. / Touma, C. / Ruppert, P. et al. | 2010
- S175
-
S.08.03 Early life stress in rodents as predictor for structural and functional neuroplasticity later in lifeJoels, M. / Van Hasselt, F. / Krugers, H. et al. | 2010
- S177
-
S.09.03 Neurotrophic factors in autismRiikonen, R. / Makkonen, I. / Kuikka, J. / Kaufmann, W. / Turpeinen, U. / Vanhala, R. / Kokki, H. et al. | 2010
- S179
-
S.10.03 Animal models of co-morbid depression and irritable bowel syndromeCryan, J. / Bravo, J. A. / Clarke, G. / Hyland, N. P. / OMalley, D. / OMahony, D. / Julio-Pieper, M. / McKernan, D. P. / Tramullas, M. / Dinan, T. G. et al. | 2010
- S180
-
S.10.05 Brain imaging in patients with gastrointestinal disordersMayer, E. A. / Labus, J. / Tillisch, K. et al. | 2010
- S182
-
S.14.01 Shared and specific vulnerability in substance abuseRamoz, N. / Le Strat, Y. / Gorwood, P. et al. | 2010
- S183
-
S.14.04 Role of glucocorticoids in alcoholismLittle, H. et al. | 2010
- S184
-
S.15.02 Modulation of dysregulated protein-protein-interactions in Huntingtons diseaseWanker, E. E. / Strodicke, M. et al. | 2010
- S185
-
S.15.05 Network-based data integration for modifier gene and drug target discovery in Huntingtons diseaseNeri, C. / Bicep, C. / Mesrob, L. et al. | 2010
- S187
-
S.16.05 N-acylethanolamines and motivated behaviour: focus on appetite disorders and alcoholismde Fonseca, F. R. / Bilbao, A. et al. | 2010
- S188
-
S.17.03 Pharmacological therapies of affective disorders influencing circadian rhythmsCorruble, E. et al. | 2010
- S190
-
S.18.05 Neurobiological mechanisms of hyperactivity in anorexia nervosaAdan, R. A. / Verhagen, L. A. / Dickson, S. L. / Egecioglu, E. / DiLeone, R. J. et al. | 2010
- S193
-
S.20.03 Nicotinic agonists in animal models of attention and working memoryShoaib, M. et al. | 2010
- S194
-
S.21.01 Weight gain and antidepressants: a meta-analysis clearly differentiates SSRIs differencesSerretti, A. et al. | 2010
- S195
-
S.21.04 Arcuate NPY/AgRP neurons and the control of energy balanceLuquet, S. / Joly, A. / Denis, R. / Palmiter, R. / Magnan, C. et al. | 2010
- S197
-
S.22.05 Neurobiological correlates of treatment response to psychoeducationColom, F. / Pacchiarotti, I. / Murru, A. / Nivoli, A. M. / Vieta, E. et al. | 2010
- S199
-
S.24.02 Cognitive endophenotypes in schizophreniaAukes, M. F. / Alizadeh, B. Z. / Kemner, C. / Sitskoorn, M. M. / Ophoff, R. A. / Kahn, R. S. et al. | 2010
- S200
-
S.24.05 Transgenic mouse models in addiction researchRobledo, P. / Martin-Garcia, E. / Plaza-Zavala, A. / Berrendero, F. / Maldonado, R. et al. | 2010
- S202
-
S.25.05 Erythropoietin and neuroprotectionEhrenreich, H. et al. | 2010
- S204
-
S.26.05 Early pharmacological intervention in PTSD: an updateZohar, J. et al. | 2010
- S205
-
S.27.03 The endocannabinoid system in neurodegeneration and psychiatryVan Laere, K. et al. | 2010
- S207
-
S.28.03 Abnormalities of glutamate and GABA systems in depression: novel findings from studies using MRS and PETHasler, G. / Deschwanden, A. / Karolewicz, B. / Buck, F. / Ametamey, S. M. / Drevets, W. C. / Van der Veen, J. W. / Shen, J. / Treyer, V. et al. | 2010
- S209
-
E.02.01 Psychotropic drugs and pain mechanismsMico, J. A. / Berrocoso, E. et al. | 2010
- S213
-
P.1.a.002 DTNBP1, HSPs and TAAR6 variations influence schizophrenic phenotype and treatment responsePae, C. / Drago, A. / Serretti, A. et al. | 2010
- S214
-
P.1.a.004 Associations between AVPR1b and NR3C1 gene variants and HPA axis responses to psychosocial stressvan West, D. / Del-Favero, J. / Deboutte, D. / Van Broeckhoven, C. / Claes, S. et al. | 2010
- S215
-
P.1.a.005 A pilot study for family based association analysis of qualitative and quantitative traits for Korean schizophrenicsLee, B. / Kwon, D. / Kim, Y. / Chung, Y. / Park, J. / Kim, S. / Kang, C. / Kim, J. / Lee, Y. et al. | 2010
- S216
-
P.1.a.007 Neurotrophin family genes (BDNF and NTRK2) and personality traits in healthy individualsKazantseva, A. / Khannanova, A. / Traks, T. / Koks, S. / Khusnutdinova, E. et al. | 2010
- S218
-
P.1.a.011 The study of prolactin gene polymophism in schizophrenic patientsRybakowski, J. K. / Dmitrzak-Weglarz, M. / Kapelski, P. / Hauser, J. et al. | 2010
- S219
-
P.1.a.013 In silico analysis of expression of orphan G protein-coupled receptor 155 during inflammation - implications for autismSwiergiel, A. H. / Juszczak, G. R. / Grochowska, K. M. et al. | 2010
- S220
-
P.1.a.015 Association of schizophrenia and dopamine b-hydroxylase (DBH) polymorphism in Korean populationMoon, D. S. / Paik, J. W. / Cho, A. R. / Kim, J. W. / Kim, E. J. / Chung, J. H. et al. | 2010
- S221
-
P.1.a.016 Biochemical and genomical characteristic of mice lacking the noradrenalin transporterSolich, J. / Palach, P. / Kusmider, M. / Gaska, M. / Faron-Gorecka, A. / Dziedzicka-Wasylewska, M. et al. | 2010
- S222
-
P.1.a.018 Alzheimers disease risk and polymorphisms of the DHCR24 geneFeher, A. / Juhasz, A. / Rimanoczy, A. / Kalman, J. / Janka, Z. et al. | 2010
- S223
-
P.1.a.020 Expression of calcyon gene in rat brain after stressfull behavioural proceduresKusmider, M. / Faron-Gorecka, A. / Gaska, M. / Gruca, P. / Papp, M. / Dziedzicka-Wasylewska, M. et al. | 2010
- S224
-
P.1.a.021 Effects of desipramine treatment on hippocampal transcriptome in mice differing in responses to antidepressantsLisowski, P. / Juszczak, G. R. / Goscik, J. / Zwierzchowski, L. / Wieczorek, M. / Swiergiel, A. H. et al. | 2010
- S225
-
P.1.a.023 Reduced sensitivity to nociceptive stimuli in mutant mice with low glutamatergic tone in the central nervous systemKayser, V. / Melfort, M. / Masson, J. / Hamon, M. / Bourgoin, S. et al. | 2010
- S227
-
P.1.b.001 Repetitive transcranial magnetic stimulation (rTMS) in the treatment of neuropatic painKlirova, M. / Fricova, J. / Sos, P. / Novak, T. / Tislerova, B. / Haeckel, M. / Masopust, V. / Rokyta, R. et al. | 2010
- S228
-
P.1.b.003 The correlation between self-rated stress response and short-term heart rate variability (HRV) in healthy femalesWoo, J. / Kim, T. / Dimsdale, J. et al. | 2010
- S231
-
P.1.b.008 Post imperative negative variation as an endophenotypic marker of schizophrenia?Castro, P. / dAlcantara, P. / Cheron, G. et al. | 2010
- S232
-
P.1.b.010 Skin conductance and electromyographic responses to different auditory stimuli in patients with schizophreniaBilgic, V. / Turkcan, A. / Ozgen, G. / Akdemir, S. / Kara, S. et al. | 2010
- S233
-
P.1.b.012 High prevalence of human herpesvirus 8 in a tunisian sample of schizophrenic patientsEl Kissi, Y. / Hannachi, N. / Samoud, S. / Gaabout, S. / Ayachi, M. / Boukadida, J. / Ali, B. B. et al. | 2010
- S234
-
P.1.b.013 Characteristics of the power spectrum alpha activity in relation to clinical expression of schizophreniaManuseva, N. / Stefanovski, B. et al. | 2010
- S235
-
P.1.c.001 Acute psychomotor, memory and subjective effects of MDMA and THC (co-) administration over time in healthy volunteersDumont, G. / van Hasselt, J. / de Kam, M. / van Gerven, J. / Touw, D. / Buitelaar, J. / Verkes, R. et al. | 2010
- S236
-
P.1.c.003 Cannabinoid mediated analgesia in rats with a central noradrenergic lesion modeling depressive-like symptomsKorossy-Mruk, E. / Brus, R. / Szkilnik, R. / Nowak, P. et al. | 2010
- S237
-
P.1.c.005 Angiotensin AT1 receptor blockade prevents memory impairment caused by chronic stressBraszko, J. et al. | 2010
- S239
-
P.1.c.008 Schizophrenia and neuroactive steroids in malesBicikova, M. / Hill, M. / Ripova, D. / Mohr, P. / Hampl, R. et al. | 2010
- S240
-
P.1.c.010 Lithium reduces neuropathic pain: involvement of opioid systemBanafshe, H. r. / Hamidi, G. / Mesdaghinia, A. / Arani, M. N. / Ramezani, M. H. et al. | 2010
- S241
-
P.1.c.012 Design, structural characterisation and biocompatibility evaluation of tramadol loaded nanoparticulate systemsTartau, L. / Garlea, A. / Melnig, V. et al. | 2010
- S243
-
P.1.c.015 Effects of AMN082, an allosteric positive modulator of presynaptic mGluR7 activity, on sleep-wake states in ratsScesa, G. / Cavas, M. / Navarro, J. F. et al. | 2010
- S244
-
P.1.c.017 New pathway involved in the alteration of reflex bradycardia in response to stress: study in rats and miceSevoz-Couche, C. / Netzer, F. / Bernard, J. F. / Hamon, M. / Benoliel, J. J. et al. | 2010
- S245
-
P.1.c.019 Effects of diazepam on contextual serial memory and hippocampal corticosterone in stressed middle-aged miceTronche, C. / Beracochea, D. / Liscia, P. / Coutan, M. / Pierard, C. et al. | 2010
- S246
-
P.1.c.021 Protective effect of Anacyclus pyrethrum against seizures and seizure-induced cognitive impairment in ratsPahuja, M. / Mehla, J. / Reeta, K. H. / Joshi, S. / Gupta, Y. K. et al. | 2010
- S247
-
P.1.c.023 Assessment of benzodiazepines-valproic acid pharmacokinetic interaction in adult epileptic patients: population approachVucicevic, K. / Miljkovic, B. / Pokrajac, M. / Prostran, M. / Martinovic, Z. / Velickovic, R. / Grabnar, I. et al. | 2010
- S249
-
P.1.c.026 Delayed effects of nociceptin analogue administration to anxiety and learning in juvenile ratsIvanova, E. A. / Malyshev, A. V. / Sarycheva, N. Y. / Dubynin, V. A. / Kalikhevich, V. N. / Ardemasova, Z. A. / Kamensky, A. A. et al. | 2010
- S250
-
P.1.c.028 The effects of atypical antipsychotic drugs on regulation of cell cycle against MPP+-induced apoptosis in PC12 cellsKim, Y. H. / Cho, H. Y. / Park, S. W. / Lee, J. G. et al. | 2010
- S251
-
P.1.c.030 Second messengers in obsessive-compulsive disorder: role of adenylate-cyclaseMarazziti, D. / Baroni, S. / Consoli, G. / DellOsso, M. C. / Giannaccini, G. et al. | 2010
- S252
-
P.1.c.031 Effect of almorexant treatment on sleep variables in patients with primary insomnia compared with healthy controlsDorffner, G. / Anderer, P. / Saletu, B. / Saletu-Zyhlarz, G. M. / Danker-Hopfe, H. / Black, J. / Dingemanse, J. / Hoever, P. et al. | 2010
- S253
-
P.1.c.033 Effect of once-daily almorexant treatment for 6 weeks on the sleep-wake cycle of normal Wistar ratsBrisbare-Roch, C. / Fischer, C. / Jenck, F. et al. | 2010
- S255
-
P.1.c.036 Nitric oxide modulation of memantine-induced deficits in sensorimotor gating in ratsSalum, C. / Henriques-Santos, N. F. / Brosco, M. C. / DelBel, E. A. et al. | 2010
- S256
-
P.1.c.038 Psychopharmacological treatment of borderline personality disorderManzanero, R. / Duran, I. / Garcia, M. / Chinchilla, A. / Cebollada, A. / Vega, M. / Soto, A. et al. | 2010
- S257
-
P.1.c.040 Impulsive aggression in a patient treated with levetiracetamMartinez, J. L. / Garrote, J. A. / Cabezas, P. M. / Pinol, G. C. / Garcia, J. C. et al. | 2010
- S258
-
P.1.c.041 Interaction study between almorexant, a dual orexin receptor antagonist, and ethanol in healthy subjectsHoch, M. / Hay, J. / Hoever, P. / de Kam, M. / van Gerven, J. / Dingemanse, J. et al. | 2010
- S259
-
P.1.c.043 Midazolam impairs acquisition but not consolidation in water maze paradigmMilinkovic, M. M. / Samardzic, J. / Divljakovic, J. M. / Joksimovic, S. M. / Timic, T. / Savic, M. M. et al. | 2010
- S260
-
P.1.c.045 Ex-vivo serotonin 5-HT1A and 5-HT2A receptor occupancy by asenapine: comparison to olanzapine and risperidoneChoi, Y. K. / Henry, B. / Shahid, M. / Tarazi, F. et al. | 2010
- S261
-
P.1.c.047 Contribution of a1 subunit-containing GABA-A receptors to diazepam-induced motor impairmentDivljakovic, J. M. / Van Linn, M. / Milinkovic, M. M. / Yin, W. / Batinic, B. / Cook, J. M. / Savic, M. M. et al. | 2010
- S262
-
P.1.c.048 Modulating effect of new L-valine derivatives on brain serotonin uptake in aggressive socially isolated miceEncheva, E. / Stancheva, S. / Alova, L. / Tancheva, L. / Petkov, V. V. / Tsekova, D. et al. | 2010
- S263
-
P.1.c.050 SRA-444: an example of early drug development decision based on a positron emission tomography studyEl Gaaloul, M. / Raje, S. / Lieuwe, A. / Hirst, W. d. / Andree, T. / Chalon, S. et al. | 2010
- S264
-
P.1.c.052 Effect of combination of ethanol with the orexin receptor antagonist almorexant or zolpidem on motor performance in ratsSteiner, M. A. / Lecourt, H. / Brisbare-Roch, C. / Jenck, F. et al. | 2010
- S265
-
P.1.c.054 Sustained administration of bupropion enhances serotonergic and noradrenergic neurotransmission in the rat hippocampusGhanbari, R. / El Mansari, M. / Blier, P. et al. | 2010
- S266
-
P.1.c.055 Electrophysiological effects of sustained administration of trazodone on serotonin systemGhanbari, R. / El Mansari, M. / Blier, P. et al. | 2010
- S267
-
P.1.c.057 Human psychopharmacology of the kappa opioid agonist salvinorin AJohnson, M. W. / Griffiths, R. R. et al. | 2010
- S268
-
P.1.c.059 Role of acetylcholine-mediated neurotransmission within pedunculopontine tegmental nucleus in the post-ictal analgesiade Oliveira, R. C. / de Oliveira, R. / Coimbra, N. C. et al. | 2010
- S269
-
P.1.c.060 Revisiting Max Hamiltons model of consensus ratings - a new approach to increase signal detection in CNS drug trialsGaur, R. / Sajatovic, M. / Lee, N. / Ramirez, L. et al. | 2010
- S270
-
P.1.c.062 Effects of glutamic acid on signaling and structural proteins of rat brain endothelial cells in ischaemic conditionsMalecki, A. / Bernacki, J. / Nierwinska, K. / Pudelko, A. / Dobrowolska, A. et al. | 2010
- S271
-
P.1.c.064 Decreased neuregulin-1 in the cortex of rat pups as immediate effect of perinatal phencyclidine treatmentPetronijevic, N. / Nikolic, T. / Radonjic, N. / Vilimanovich, U. / Trajkovic, V. / Bumbairevic, V. et al. | 2010
- S273
-
P.1.c.067 Effect of group II metabotropic glutamate receptor agonist on behaviour and electroencephalography in a model of psychosisFujakova, M. / Palenicek, T. / Gorman, I. / Brunovsky, M. et al. | 2010
- S274
-
P.1.d.002 Effect of semi-purified constituent from guarana seeds on performance of rats in elevated T mazeAudi, E. A. / Roncon, C. M. / Almeida, C. B. / Mello, J. C. et al. | 2010
- S275
-
P.1.d.004 Cyclooxygenase-2 inhibition by nimesulide may reduce the incidence of pentylenetetrazole-induced seizure in miceMesdaghinia, A. / Heydari, A. / Khazaee, P. / Yazdanpanah, H. et al. | 2010
- S277
-
P.1.d.007 Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in ratsChoi, M. S. / Oh, Y. M. / Chung, Y. C. et al. | 2010
- S278
-
P.1.d.009 Longterm memory formation in non-association learning task in sham-operated and dentate gyrus lesioned ratsNaneishvili, T. / Dashniani, M. / Beselia, G. / Noselidze, A. / Kruashvili, L. et al. | 2010
- S279
-
P.1.d.011 Effects of excitotoxic lesions of the CA1 region of the hippocampus on acquisition of a place and cue water maze taskChkhikvishvili, N. / Burjanadze, M. / Maglakelidze, G. / Sakandelidze, R. et al. | 2010
- S280
-
P.1.d.013 Influence of D1 and D2 antagonists on mother-dependent behaviour of 10 and 15 days old albino rat pupsStovolosov, I. / Dubynin, V. / Kamensky, A. et al. | 2010
- S281
-
P.1.d.014 HFS and pharmacological inactivation of the globus pallidus and nucleus entopeduncularis differentially affect quinpirole-induced compulsive checking in ratsDjodari-Irani, A. / Klein, J. / Banzhaf, J. / Juckel, G. / Heinz, A. / Kupsch, A. / Morgenstern, R. / Winter, C. et al. | 2010
- S282
-
P.1.d.016 Acute effects of modafinil on affective behaviour in aggressive and timid male miceMachalova, A. / Vrskova, D. / Slais, K. / Sulcova, A. et al. | 2010
- S283
-
P.1.d.018 Memory consolidation via membrane glucocorticoid receptors that can be blocked by cannabinoid receptor antagonistsHauer, D. / Fornari, R. V. / Atsak, P. / Campolongo, P. / Schelling, G. / Roozendaal, B. et al. | 2010
- S284
-
P.1.d.020 Role of interferon-gamma on anxiety-like behaviour in miceSaito, V. M. / Rodrigues, D. H. / Teixeira, A. L. / Moreira, F. A. et al. | 2010
- S285
-
P.1.d.022 GABAergic synaptic coverage of principal cells in the hippocampus in the rat model of schizophreniaRadonjic, N. / Jakovcevski, I. / Bumbasirevic, V. / Petronijevic, N. et al. | 2010
- S287
-
P.1.d.025 The involvement of oxidative stress in some cognitive effects of angiotensin II and angiotensin 1-7 in ratsCiobica, A. / Hritcu, L. / Haulica, I. / Popescu, R. / Bild, V. et al. | 2010
- S288
-
P.1.e.002 Diffusion tensor imaging findings in early-onset schizophrenia patientsGawlowska, M. / Gebski, P. / Rabe-Jablonska, J. et al. | 2010
- S290
-
P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI studyBossong, M. G. / van Hell, H. H. / Jager, G. / Oudman, F. A. / Kahn, R. S. / Ramsey, N. F. et al. | 2010
- S292
-
P.1.e.008 Impact of genetic polymorphism on resting state functional connectivity in healthy subjectsByun, M. S. / Jung, W. H. / Jang, J. H. / Kang, D. H. / Kwon, S. J. / Choi, C. H. / Kwon, J. S. et al. | 2010
- S293
-
P.1.e.010 The effect of COMT Val108/158Met Polymorphism on brain activations in response to negative affective facial stimuliByung-Joo, H. / In-Kwa, J. et al. | 2010
- S294
-
P.1.e.012 Is there a link between amygdala volume, cognitive function and childhood trauma in first-episode psychosis?Aas, M. / Dazzan, P. / Gibbs, A. / Morgan, C. / Fisher, H. L. / Reichenberg, A. / Zanelli, J. / Morgan, K. / Murray, R. / Pariante, C. M. et al. | 2010
- S296
-
P.1.e.015 Emotion cognition interaction located using surface-based versus volume-based analysisHuf, W. / Pail, G. / Hartinger, B. / Kasess, C. / Kasper, S. / Mattay, V. S. / Meyer-Lindenberg, A. / Moser, E. / Weinberger, D. R. / Pezawas, L. et al. | 2010
- S297
-
P.1.e.017 Delta9-THC causes alterations in impulse regulation-related brain function: new insights from a pharmaco-imaging studyNoorman, K. / van Hell, H. H. / Bossong, M. G. / Ramsey, N. F. / Jager, G. et al. | 2010
- S298
-
P.1.e.018 Focal and global brain measurements in non-psychotic siblings of patients with schizophreniaBoos, H. / Cahn, W. / Van Haren, N. E. / Derks, E. M. / Brouwer, R. M. / Schnack, H. G. / Pol, H. E. / Kahn, R. S. et al. | 2010
- S299
-
P.1.e.021 In vivo assessment of changes in serotonin release in the non-human primate brain using PET and [11C]AZ10419369Finnema, S. J. / Varrone, A. / Hwang, T. J. / Farde, L. / Halldin, C. et al. | 2010
- S300
-
P.1.e.023 Dopaminergic activity in Tourettes syndrome and obsessive-compulsive disorderde Vries, F. E. / Denys, D. / Cath, D. C. / Figee, M. / Veltman, D. J. / van der Doef, T. F. / Boellaard, R. / Balkom, A. J. / Lammertsma, A. A. / van Berckel, B. N. et al. | 2010
- S301
-
P.1.e.024 Effect of antidepressant treatment on the neural circuitry in dysthymia: a functional magnetic resonance imaging studyRavindran, A. / Smith, A. / Georgescu, T. / Cameron, C. / Bhatla, R. / Hogan, M. et al. | 2010
- S302
-
P.1.e.026 [11C]AF150(S): a putative agonist PET ligand for in vivo imaging of the M1 muscarinic acetylcholine receptorLeysen, J. E. / Buiter, J. C. / Fisher, A. / Huisman, M. C. / Yaqub, M. / Boellaard, R. / Lammertsma, A. A. / Windhorst, A. D. et al. | 2010
- S303
-
P.1.e.028 Increase of whole brain volume and gray and white matter tissue in OCD: a volumetric and voxel-based morphometry MRI studySobanski, T. / Wagner, G. / Peikert, G. / Gruhn, U. / Sauer, H. / Schlosser, R. G. et al. | 2010
- S304
-
P.1.e.030 Clinical response of neuronavigated repetitive-TMS in the treatment of auditory hallucinationsKlirova, M. / Horacek, J. / Novak, T. / Cermak, J. / Tislerova, B. / Tintera, J. et al. | 2010
- S305
-
P.1.f.001 Temperament and character profiles in female fibromyalgia syndrome patients and healthy controlsAltunoren, O. / Orhan, F. O. / Nacitarhan, V. / Ozer, A. / Karaaslan, M. F. et al. | 2010
- S306
-
P.1.f.003 Psychopathology assessment of fifty patients with morbid obesity who applied for bariatric surgeryMartinez, E. P. / van der Hofstadt, C. J. / Gonzalez, S. T. / Vicente, M. M. et al. | 2010
- S308
-
P.1.g.001 A prospective investigation of postconcussional symptoms after mild traumatic brain injuryHou, R. / Peveler, R. / Moss-Morris, R. / Belli, A. / McVeigh, S. / Bradley, B. / Mogg, K. et al. | 2010
- S309
-
P.1.g.003 Cognitive and perceptual processing in body dysmorphic disorderJefferies, K. / Laws, K. / Hranov, G. / Fineberg, N. A. et al. | 2010
- S311
-
P.1.g.006 Cognitive function in hepatitis C patients: effect of pegylated interferon a and ribavirin therapyel Meguid, M. A. / Moussa, M. et al. | 2010
- S312
-
P.1.g.008 Cognitive effects of electrode placement and stimulus dose in brief-pulse electroconvulsive therapy for depressionSemkovska, M. / Babalola, O. / Keane, D. / McLoughlin, D. M. et al. | 2010
- S313
-
P.1.g.009 Evaluation of an emotional tone discrimination task in humans as a potential method for assessing cognitive biasAnderson, M. H. / Robinson, E. S. / Munafo, M. R. et al. | 2010
- S314
-
P.1.g.011 Assessing cognitive impairment to define needs for care in a sample of chronic outpatients with schizophreniaCerveri, G. / Venturi, V. / Volonteri, L. S. / Mazzocchi, A. / Mencacci, C. et al. | 2010
- S315
-
P.1.g.013 Chronic pravastatin but not atorvastatin impairs cognitive function in two rodent models of learning and memoryStuart, S. A. / Robertson, J. D. / Marrion, N. V. / Robinson, E. S. et al. | 2010
- S316
-
P.1.g.015 A cognitive behavioural therapy group treatment program for body dysmorphic disorder: preliminary resultsMolenaar, C. A. / Vulink, N. C. / Denys, D. A. et al. | 2010
- S318
-
P.1.g.018 Genetic, neurophysiologic and behavioural factors in human risk taking behaviour: an endophenotypeHeitland, I. / Oosting, R. S. / Baas, J. M. / Kenemans, J. L. / Bocker, K. B. et al. | 2010
- S319
-
P.1.g.020 Computerised cognitive testing in schizophrenia: patients experiencesPandey-Bhat, S. / Nath, G. / Arneja, A. / Sharma, A. / Kaviani, H. / De Santi, S. et al. | 2010
- S320
-
P.1.g.022 Decision-making in euthymis bipolar disorders: their relationship with suicidal behaviourMartino, D. J. / Strejilevich, S. A. / Torralva, T. / Manes, F. et al. | 2010
- S321
-
P.1.g.023 No evidence of differences in neurocognitive functioning among euthymic bipolar I and bipolar II disordersMartino, D. J. / Igoa, A. / Marengo, E. / Fassi, G. / Strejilevich, S. A. et al. | 2010
- S322
-
P.1.h.001 Comparison of treated and untreated major depressive disorder in a nationwide sample of Korean adultsKim, K. / Park, S. / Choi, J. W. / Park, J. I. / Hong, J. P. / Cho, M. J. et al. | 2010
- S323
-
P.1.h.003 Prevalence of metabolic syndrome and cardiovascular risk in patients with schizoaffective disordersBenabarre, A. / Garcia-Portilla, M. P. / Livianos, L. / Mesa, F. et al. | 2010
- S324
-
P.1.h.004 Health-related quality of life of psychiatric disorders and somatic disorders in a nationwide sample of South KoreaCho, S. J. / Hong, J. P. / Chang, S. / Lee, J. Y. / Cho, M. J. et al. | 2010
- S325
-
P.1.h.006 Detection of substances of abuse in emergency department: is there an increasing the use of benzodiazepines?Gibert, M. M. / Calvo, R. P. / Rueda, L. M. / Serven, E. G. / Gomez, A. A. / de Santiago, E. B. et al. | 2010
- S326
-
P.1.h.008 Aggression on a psychiatric acute ward: predictors and clinical assessmentsStinga, M. / Papastergios, C. / Papanikolaou, K. / Papageorgiou, E. / Ntavou, M. / Voura, N. / Angelidis, G. F. et al. | 2010
- S328
-
P.1.i.002 Changes in cerebrospinal fluid insulin during non-neurological surgeryBromander, S. / Anckarsater, R. / Ahren, B. / Kristiansson, M. / Blennow, K. / Zetterberg, H. / Anckarsater, H. / Wass, C. et al. | 2010
- S329
-
P.1.i.004 A randomized, three phase 34 week double-blind long-term efficacy study of extended-release methylphenidate in adults with ADHDBiederman, J. / Mick, E. et al. | 2010
- S330
-
p.1.i.005 Long-term functional effects on circadian rhythm caused by a single MDMA treatmentKatai, Z. / Garay, T. / Balogh, B. / Kirilly, E. / Bagdy, G. et al. | 2010
- S332
-
p.1.i.009 Behavioural and neurochemical characterisation of central neuropathic pain after spinal cord transection in the ratMDahoma, S. / Massart, R. / Chali, F. / Orsal, D. / Chevarin, C. / Kayser, V. / Bourgoin, S. / Hamon, M. et al. | 2010
- S333
-
P.2.a.001 Cyclothymic and hyperthymic temperaments in depressive patientsGoto, S. / Terao, T. / Araki, Y. / Hoaki, N. / Wang, Y. M. / Takai, Y. et al. | 2010
- S334
-
P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO3 levelsIkenouchi-Sugita, A. / Yoshimura, R. / Kishi, T. / Umene-Nakano, W. / Hori, H. / Hayashi, K. / Katsuki, A. / Iwata, N. / Nakamura, J. et al. | 2010
- S336
-
P.2.a.006 Predictors of remission in a national sample of patients with depressive disorders: the CRESCEND studyKim, J. M. / Yoo, J. A. / Yang, S. J. / Kim, S. W. / Shin, I. S. / Yoon, J. S. / Kim, J. B. / Lee, M. S. / Lim, H. W. / Jun, T. Y. et al. | 2010
- S337
-
P.2.a.008 Gender differences in 12 week treatment outcomes in Korean depressive patients: a report of CRESCEND studyYang, S. / Yoo, J. / Bae, K. / Kim, J. / Shin, I. / Kim, S. / Yoon, J. et al. | 2010
- S339
-
P.2.a.011 Cyclothymic and hyperthymic temperaments in depressive patients: supportive evidence for bipolar ii1/2 and iv3Araki, Y. et al. | 2010
- S340
-
P.2.a.013 Effect of escitalopram on depressive symptoms in patients with coronary artery stentsYuryeva, L. N. / Mamchur, A. I. / Dukelskiy, A. A. et al. | 2010
- S341
-
P.2.a.015 Transcranial direct current stimulation in patients with treatment-resistant major depressive episodeDellOsso, B. / Zanoni, S. / Castellano, F. / Dobrea, C. / Benatti, B. / Arici, C. / Ferrucci, R. / Vergari, M. / Priori, A. / Altamura, A. C. et al. | 2010
- S342
-
P.2.a.016 Cytokine profile in treatment-resistant depressionCarvalho, L. A. / Torre, J. P. / Cleare, A. J. / Pariante, C. M. et al. | 2010
- S343
-
P.2.a.018 Influences between defense mechanisms and antidepressants on the therapeutic compliance in major depressive disorderVasile, D. / Vasiliu, O. / Vasile, M. L. / Terpan, M. / Mangalagiu, A. / Bogdan, V. / Ojog, D. / Petrescu, M. B. / Paraico, I. et al. | 2010
- S344
-
P.2.a.020 Treatment of breast cancer patients with comorbid serious anxiety and depressionSnoj, Z. / Zakelj, M. P. / Miklavcic, I. V. / Licina, M. / Pregelj, P. et al. | 2010
- S345
-
P.2.a.021 Factors influencing antidepressant adherence in the patients with depressive disorderMoon, D. S. / Paik, J. W. / Kim, J. W. / Cho, A. R. et al. | 2010
- S346
-
P.2.a.023 HPA axis hyperactivity is a vulnerability factor for switch to depressive disorder following interferon treatmentEccles, J. / Lallemant, C. / Mushtaq, F. / Greenwood, M. / Keller, M. / Haq, I. / Tibble, J. / Whale, R. et al. | 2010
- S347
-
P.2.a.025 Dopamine transporter gene play a risk factor in patient with major depressive disorder?Huang, C. / Shy, M. J. et al. | 2010
- S348
-
P.2.a.026 Superior efficacy results of agomelatine in a pooled analysis versus SSRI/SNRIKasper, S. / Hale, A. / Lemoine, P. / Salva, M. A. et al. | 2010
- S349
-
P.2.a.028 The effect of the number of depressive episodes on fatigue in female patients with major depressionFerentinos, P. / Kontaxakis, V. P. / Havaki-Kontaxaki, B. J. / Dikeos, D. / Papadimitriou, G. N. / Lykouras, L. et al. | 2010
- S350
-
P.2.a.030 Deliberate self-harm and suicidal ideation in naturalistic outpatients: the Leiden routine outcome monitoring studyvan Noorden, M. S. / de Klerk, S. / Giezen, A. E. / Spinhoven, P. / den Hollander-Gijsman, M. E. / Giltay, E. J. / Speckens, A. E. / Zitman, F. G. et al. | 2010
- S351
-
P.2.a.031 Prednisolone suppression test, but not dexamethasone predicts outcome in treatment resistant depressionJuruena, M. F. / Pariante, C. M. / Papadopoulos, A. S. / Poon, L. / Lightman, S. / Cleare, A. J. et al. | 2010
- S352
-
P.2.a.033 Therapy of anxiety-depressive disorders in outpatient cardiologic practiceGarganeyeva, N. / Rozin, A. I. / Evsyukov, A. A. / Kaskayeva, D. S. / Donov, A. V. et al. | 2010
- S353
-
P.2.b.001 Water extract of saffron (Crocus sativus) increases brain dopamine and glutamate concentration in the ratShams, J. / Hedayati, M. / Asefi, F. / Sahraei, H. et al. | 2010
- S355
-
P.2.b.004 Interconnectedness of homocysteine and affective disordersPurvina, S. / Kevere, L. / Bauze, D. / Zeibarts, M. / Rizevs, A. / Jelisejevs, S. / Caune, M. / Purvins, I. / Andrezina, R. et al. | 2010
- S356
-
P.2.b.006 Cognitive deficits and salivary cortisol in major depression: effects of treatmentHinkelmann, K. / Moritz, S. / Muhtz, C. / Botzenhard, J. / Wiedemann, K. / Kellner, M. / Otte, C. et al. | 2010
- S357
-
P.2.b.008 Effect of different antidepressants on behavioural alterations induced by chronic social defeat stressVenzala, E. / Garcia-Garcia, A. L. / Elizalde, N. / Delagrange, P. / Tordera, R. et al. | 2010
- S358
-
P.2.b.010 Antidepressant-like features of mice with transgenic activation of Ras in differentiated neuronsLeske, O. / Bichler, Z. / Heumann, R. et al. | 2010
- S359
-
P.2.b.011 In search for a tool selectively evaluating depressive symptoms associated with different neurotransmitter systemsFaludi, G. / Gonda, X. / Bekes, V. / Meszaros, V. / Sarosi, A. / Olah, A. et al. | 2010
- S360
-
P.2.b.013 Mice with decreased vesicular glutamate transporter VGLUT1 levels show an altered presynaptic 5-HT functionGarcia-Garcia, A. L. / Elizalde, N. / Venzala, E. / Del Rio, J. / Lanfumey, L. / Tordera, R. M. et al. | 2010
- S361
-
P.2.b.015 Mediating role of psychological immune competencies on the development of susceptibility to depressionPap, D. / Gonda, X. / Lazary, J. / Molnar, E. / Tothfalusi, L. / Bagdy, G. et al. | 2010
- S362
-
P.2.b.017 Defining endophenoypes in major depressive disorder: anhedonia, neuroticism and psychomotor speedVrieze, E. / Demyttenaere, K. / Bruffaert, R. / Schmidt, M. / de Boer, P. / Claes, S. et al. | 2010
- S363
-
P.2.b.018 Mouse communal nest: early social enrichment blunts adult depression-like phenotype altering BDNF epigenetic structureBranchi, I. / DAndrea, I. / Santarelli, S. / Cirulli, F. / Karpova, N. / Castren, E. / Alleva, E. et al. | 2010
- S364
-
P.2.b.020 Changes in gene expression in the rat brain induced by partial serotonergic denervation and chronic variableAlttoa, A. / Kanarik, M. / Harro, J. et al. | 2010
- S365
-
P.2.b.022 Serum BDNF levels correlate with arousal status in womenBersani, G. / Iannitelli, A. / TIrassa, P. / Cirulli, F. / Branchi, I. / Aloe, L. / Alleva, E. et al. | 2010
- S366
-
P.2.b.024 Lithium preferentially increases neurogenesis in the ventral but not dorsal hippocampus of stressed BALB/c miceOLeary, O. F. / OConnor, R. M. / Cryan, J. F. et al. | 2010
- S367
-
P.2.c.001 Adding an atypical antipsychotic drug induced a rapid increase of plasma BDNF levels in refractory depressionYoshimura, R. / Ikenouchi-Sugita, A. / Hori, H. / Umene-Nakano, W. / Katsuki, A. / Hayashi, K. / Nakamura, J. et al. | 2010
- S369
-
P.2.c.004 Response to paroxetine and sodium valproate in PTSD: gender differences, efficacy and tolerabilityArslanagic, G. S. / Kucukalic, A. / Bise, S. et al. | 2010
- S370
-
P.2.c.006 The effect of repetitive transcranial magnetic stimulation in major depressive disorder partial remissionCharnsil, C. / Suttajit, S. / Bunyanarutee, V. / Lelaput, S. et al. | 2010
- S372
-
P.2.c.009 The effect of major depression, SSRI and gepirone-extended-release treatment on sexual function in womenFabre, L. et al. | 2010
- S373
-
P.2.c.011 The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patientsIgnjatovic, A. R. / Miljkovic, B. / Todorovic, D. / Timotijevic, I. / Pokrajac, M. et al. | 2010
- S374
-
P.2.c.013 New functional variant in SLC6A4 gene as candidate of the individualised treatment of depression - the result of an RCT -Kato, M. / Tetsuo, S. / Wakeno, M. / Nonen, S. / Okugawa, G. / Takekita, Y. / Azuma, J. / Kinoshita, T. et al. | 2010
- S375
-
P.2.c.014 Agomelatine: a new therapeutic prospective in depressionIstikoglou, C. / Foutsitzis, D. / Vlavianou, A. / Kanellos, P. / Polonifis, N. / Vlissides, D. / Michelidakis, K. / Theodorakopoulos, G. et al. | 2010
- S376
-
P.2.c.016 Sertraline versus mirtazapine in treatment of depression in Parkinsons diseaseDjokic, G. / Pavicevic, D. / Zivkovic, N. / Nenadovic, M. / Nenadovic, N. / Duisin, D. et al. | 2010
- S377
-
P.2.c.018 Safety of quetiapine for treatment of insomnia in patients with major depressive disorderLee, S. / Han, J. H. / Hong, S. C. / Jeong, J. H. / Seo, H. J. / Lim, H. K. et al. | 2010
- S378
-
P.2.c.019 Polypharmacy in psychiatry: clinical practice versus empirical evidenceLotscher, K. / Anghelescu, I. G. / Braun, S. / Bridler, R. / Stassen, H. H. et al. | 2010
- S379
-
P.2.c.021 Agomelatine facilitates positive emotional processing in healthy volunteersGoodwin, G. M. / de Bodinat, C. / Dawson, G. R. / Dourish, C. T. / Waldenmaier, L. / Adams, S. / Cowen, P. J. / Harmer, C. J. et al. | 2010
- S380
-
P.2.c.023 Sleep architecture in olanzapine treated patients with depression: a double blind randomized placebo controlled trialMilev, R. / Lazowski, L. / Lowe, A. / Jokic, R. / du Toit, R. et al. | 2010
- S381
-
P.2.c.024 Switching to second line antidepressant in the United Kingdom: main characteristics and determinantsChollet, J. / Saragoussi, D. / Despiegel, N. / Maman, K. / Milea, D. et al. | 2010
- S382
-
P.2.c.026 Antidepressants for late-life depression: a meta analysis of placebo-controlled randomized trialsTedeschini, E. / Levkovitz, Y. / Papakostas, G. et al. | 2010
- S383
-
P.2.c.028 Effect of a single dose (50 mg) of agomelatine on bold fMRI responses to face emotion recognition in healthy volunteersLees, J. / McKie, S. / Dadhiwala, R. / Horgan, P. / Dawson, G. / Seguin, L. / Mocaer, E. / Deakin, J. F. et al. | 2010
- S384
-
P.2.c.030 Serum brain-derived neurotrophic factor levels as predictor of antidepressant therapy responseEckert, A. / Giese, M. / Beck, J. / Brand, S. / Muheim, F. / Hatzinger, M. / Holsboer-Trachsler, E. et al. | 2010
- S385
-
P.2.c.031 Genotypic and phenotypic CYP2D6 poor metaboliser status in depressed patients treated with venlafaxine extended releaseKane, C. / Nichols, A. / Chhaya, V. / Buckley, G. / Guico-Pabia, C. et al. | 2010
- S386
-
P.2.c.033 Influence and interaction of genetic polymorphisms in serotonin system and early life stress on antidepressant responseZhang, Z. J. / Xu, Z. / Shi, Y. Y. / Pu, M. J. / Wang, C. Y. / Liu, Z. N. / Reynolds, G. P. et al. | 2010
- S388
-
P.2.c.036 Associations of gene-gene interaction in the Ras-Raf-MAPK signal pathway with antidepressant drug responseZhang, Z. J. / Wang, C. J. / Pu, M. J. / Xu, Z. / Wang, C. Y. / Liu, Z. N. et al. | 2010
- S390
-
P.2.c.039 Noradrenergic uptake inhibition of higher doses of paroxetine in relation to clinical efficacy: the DELPHI-studyRuhe, H. G. / van Westrhenen, R. / Koeter, M. W. / Michel, M. C. / Sitte, H. H. / Schene, A. H. et al. | 2010
- S392
-
P.2.d.003 The omega-3 polyunsaturated fatty acid docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microgliaSu, K. / Lu, D. Y. / Tsao, Y. Y. et al. | 2010
- S393
-
P.2.d.006 Role of PSA-NCAM in the structural plasticity associated to dopaminergic antidepressants in the medial prefrontal cortexCastillo-Gomez, E. / Gomez-Climent, M. A. / Garcia-Mompo, C. / Nacher, J. et al. | 2010
- S394
-
P.2.d.008 Effects of single and chronic agomelatine administration on Galpha(i) proteins expression in the rat brainChmielarz, P. / Wieczerzak, K. / Zelek-Molik, A. / Kusmierczyk, J. / Bielawski, A. / Nalepa, I. et al. | 2010
- S396
-
P.2.d.011 Low dose pipamperone, enhancing antidepressant effect of citalopram, occupies 5HT2A 50-60% leaving D2 nearly drug freeBuntinx, E. / Bol, K. / van den Berg, P. / Spaans, E. / Haazen, L. et al. | 2010
- S397
-
P.2.d.013 Differential noradrenergic and serotonergic modulation of the neural correlates of the processing of emotional picturesBruehl, A. B. / Kaffenberger, T. / Jancke, L. / Herwig, U. et al. | 2010
- S398
-
P.2.d.014 Changes in genes and proteins level of Nr4a1, Egr1 and Id1 in rat brain after antidepressant treatmentGaska, M. / Kusmider, M. / Solich, J. / Faron-Gorecka, A. / Dziedzica-Wasylewska, M. et al. | 2010
- S399
-
P.2.d.016 Postweaning enriched environment and citalopram overcome memory deficits and anhedonia induced by maternal separationZhang, Z. / Liu, S. S. / Hui, J. J. et al. | 2010
- S400
-
P.2.d.018 Analysis of the effects of chronic antidepressant treatment on neuronal plasticity in middle-aged ratsGuirado, R. / Hernandez, S. / Vidueira, S. / Nacher, J. et al. | 2010
- S401
-
P.2.d.020 Serum VEGF during electroconvulsive therapy (ECT) in drug resistant depressed patientsMinelli, A. / Zanardini, R. / Abate, M. / Bortolomasi, M. / Gennarelli, M. / Chiavetto, L. B. et al. | 2010
- S402
-
P.2.e.002 Relationship between clinical characteristics, objective psychopathology and subjective deficits of bipolar disorderJoe, S. / Kwon, D. / Cho, S. et al. | 2010
- S404
-
P.2.e.005 Mood stabilisers and atypical antipsychotics in the long-term treatment of bipolar disorderAltamura, A. C. / Buoli, M. / Paoli, R. A. / Primavera, D. et al. | 2010
- S405
-
P.2.e.007 Outcome of bipolar illness and comorbid personality disorderLopez, O. G. / Fernandez-Arguelles, P. / Casas, N. / Camacho, M. / Garcia, J. M. et al. | 2010
- S406
-
P.2.e.009 Gender differences in bipolar disordersNivoli, A. M. / Colom, F. / Rosa R, A. / Popovic, D. / Pacchiarotti, I. / Murru, A. / Vieta, E. et al. | 2010
- S407
-
P.2.e.010 Effectiveness of quetiapine versus bupropion as adjunctive treatment in bipolar depressionLee, K. J. / Kim, H. et al. | 2010
- S408
-
P.2.e.012 Use of traditional and alternative therapies in people who suffer bipolar disorders: impact on complianceStrejilevich, S. / Scapola, M. / Martino, D. / Sarmiento, M. / Gil, L. / Restrepo, C. G. et al. | 2010
- S409
-
P.2.e.014 Combined antidepressant and quetiapine therapy in bipolar I mixed - one-year follow upCallista, G. / Daneluzzo, E. et al. | 2010
- S410
-
P.2.e.015 Clinical trials to clinical practice: retrospective analysis of 25 patients with bipolar mania treated with aripiprazoleRana, T. et al. | 2010
- S411
-
P.2.e.017 Life-time suicide attempts in acutely admitted inpatients with bipolar disorderFinseth, P. I. / Morken, G. / Malt, U. F. / Andreassen, O. A. / Vaaler, A. E. et al. | 2010
- S412
-
P.2.e.019 Thyroid function assessment in lithium-treated patients: preliminary resultsLagoudis, A. / Iakovou, I. / Christoforidis, T. / Stergiokoglou, C. / Syngelakis, M. / Garyfallos, G. / Bozikas, V. et al. | 2010
- S413
-
P.2.e.021 Aripiprazole in combination with lamotrigine: long-term treatment of patients with bipolar I disorder (manic or mixed)Ketter, T. / Carlson, B. X. / Sun, W. / Timko, K. / Vester-Blokland, E. / McQuade, R. D. / Sanchez, R. / Owen, R. et al. | 2010
- S414
-
P.2.e.022 Lamotrigine adjunctive therapy and possible sleep regulation in adult autism spectrum disorder: a case reportOoga, K. / Abe, Y. / Okudaira, T. / Suzuki, Y. / Ishikawa, Y. / Furukawa, Y. / Kojima, T. et al. | 2010
- S415
-
P.2.e.024 Cytokine profiles in bipolar affective disorder during acute episodes and in remissionRemlinger-Molenda, A. / Wojciak, P. / Kostrzewa, A. / Karczewski, J. / Wiktorowicz, K. / Rybakowski, J. K. et al. | 2010
- S416
-
P.2.e.026 Parenting and family planning characteristics among bipolar mothers compared to controlsMoreno, D. H. / Bio, D. / Petresco, S. / Petresco, D. / Gutt, E. / Moreno, R. A. et al. | 2010
- S418
-
P.2.f.002 Selective DNA methylation of BDNF promoter in bipolar disorderDAddario, C. / DellOsso, B. / Galimberti, D. / Scarpini, E. / Arosio, B. / Bergamaschini, L. / Fenoglio, C. / Candeletti, S. / Romualdi, P. / Altamura, A. C. et al. | 2010
- S419
-
P.2.f.004 Anti-estrogenic drugs do not reproduce the antimanic-like effect of tamoxifen in methylphenidate-induced hyperlocomotionAndreatini, R. / Pereira, M. / Martynhak, B. J. / Baretta, I. P. / Correia, D. et al. | 2010
- S421
-
P.2.g.002 Sexual dysfunction in depressed subjects with enduring personality change (F62.0) taking mirtazapineStojakovic, M. / Vukadinovic, S. / Stojakovic, B. / Trkulja, D. / Medenica, S. / Selman, N. et al. | 2010
- S422
-
P.2.g.004 Bupropion for adults with ADHD: meta-analysis of randomised, placebo-controlled trialsManeeton, N. / Maneeton, B. / Srisurpanont, S. et al. | 2010
- S424
-
P.2.g.007 Standard antidepressant therapy vs association between amisulpride and antidepressant therapy in atypical depressionGrigorescu, G. / Baloescu, A. / Vasile, D. / Tudor, C. / Vasiliu, O. / Grigorescu, R. et al. | 2010
- S425
-
P.2.g.009 The incidence of psychiatric disorders in patients with hyperthyroidismChenderes, R. / Podea, D. M. / Stamoran, L. / Nanu, P. D. / Mila, C. / Piros, L. E. / Mihailescu, N. et al. | 2010
- S426
-
P.2.g.011 Implications of oxidative stress in patients with depressive disorder and insomniaVitalaru, R. / Padurariu, M. / Cantemir, A. / Ciobica, A. / Stefanescu, C. et al. | 2010
- S427
-
P.2.h.001 Polymorphisms in the BDNF gene are associated with antidepressant treatment responseHennings, J. / Kohli, M. / Heck, A. / Roeske, D. / Bruckl, T. / Klengel, T. / Menke, A. / Muller-Myhsok, B. / Ising, M. / Holsboer, F. et al. | 2010
- S428
-
P.2.h.003 Suicide attempts in a mental health unit of GaliciaTraba, B. P. / Garcia, M. P. / Ansorena, A. M. et al. | 2010
- S429
-
P.3.a.001 Evaluation of the effect of aripiprazole on quality of life in patients with schizophreniaBervoets, C. / Constant, E. / Sabbe, B. / Morrens, M. / Vansteelandt, K. / De Patoul, A. / Pitzi, D. / Halkin, V. / Loze, J. Y. / Peuskens, J. et al. | 2010
- S430
-
P.3.a.002 Evaluation of theta burst stimulation on the resistant auditory hallucinations: a pilot studySidhoumi, D. / Braha, S. / Bouaziz, N. / Benadhira, R. / Januel, D. et al. | 2010
- S431
-
P.3.a.004 Clinical variables, cognitive assessment and positron emission tomography (PET) in schizophrenic inpatientsBuoli, M. / Caletti, E. / Serati, M. / Paoli, R. A. / DellOsso, B. / Altamura, A. C. et al. | 2010
- S432
-
P.3.a.006 Attitudes concerning depot medication in German general population - a representative telephone surveyCordes, J. / Arnau, S. / Hoppe, K. / Thunker, J. / Wittib, I. et al. | 2010
- S433
-
P.3.a.007 Subjective well-being in schizophrenia is inversely correlated with the presence and severity of depressive symptomsSanjuan, J. / Haro, J. M. / Maurino, J. / Diez, T. / Ballesteros, J. et al. | 2010
- S434
-
P.3.a.009 Negative symptoms: neglected but important targets for treatmentHunter, R. / Barry, S. et al. | 2010
- S435
-
P.3.a.011 Descriptive study of suicidal behaviour in delusional disorderGarcia, M. P. / Ansorena, A. M. / Traba, B. P. / Fernandez, M. P. / Gonzalez, J. B. et al. | 2010
- S436
-
P.3.a.013 Fatigue, sleepiness and sleep quality in psychotic disordersWidakowich, C. / Neu, D. / Nagant, V. / Steegen, G. / Verbanck, P. et al. | 2010
- S438
-
P.3.a.016 Importance of demographic factors and neuropsychological functioning in schizophrenic patients treated with olanzapineKrysta, K. / Borkowska, A. / Bielinski, M. et al. | 2010
- S439
-
P.3.a.018 A role for structural equation modeling in subtyping schizophrenia in an African populationKoen, L. / Niehaus, D. J. / Emsley, R. A. / Jordaan, E. et al. | 2010
- S440
-
P.3.a.020 Weight gain as a marker of evolution to patients with multiple episodes schizophrenia and depressive symptomsMarinescu, I. / Marinescu, D. / Pirlog, M. / Chimorgiachis, A. et al. | 2010
- S441
-
P.3.a.022 QoL of schizophrenic inpatients treated with risperidone or haloperidolVukic, D. et al. | 2010
- S442
-
P.3.a.024 Risk for coronary heart disease in inpatients with serious mental illnessNtounas, P. / Tsopelas, C. / Vlachos, I. / Sovolakis, I. / Gkeka, E. / Psaras, R. / Siouti, E. / Touloumis, C. et al. | 2010
- S444
-
P.3.a.027 Prediction of un-planned readmission to hospital for patients with schizophrenia - a cohort-study of 277 patientsKroken, R. / Mellesdal, L. S. / Jorgensen, H. A. / Wentzel-Larsen, T. / Johnsen, E. et al. | 2010
- S445
-
P.3.a.029 Acute and transient psychosis: focus on clinical features and stressful life events before the first episodeRancans, E. / Rusaka, M. et al. | 2010
- S446
-
P.3.a.031 Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in TaiwanChang, H. / Su, K. / McCropne, P. et al. | 2010
- S447
-
P.3.a.033 Electrophysiological measures and clinical scales in schizophrenia and bipolar disorderDomjan, N. / Csifcsak, G. / Szendi, I. / Janka, Z. et al. | 2010
- S448
-
P.3.a.035 Cognitive responce as a predictor of repetitive transcranial magnetic stimulation (rTMS) efficacy in schizophreniaMaslenikov, N. / Tsukarzi, E. E. / Mosolov, S. N. et al. | 2010
- S449
-
P.3.a.037 Hyperactivation of inflammatory response in depressed patients with psychomotor retardationCamardese, G. / Leone, B. / Mattioli, B. / Pizi, G. / Bria, P. et al. | 2010
- S450
-
P.3.a.038 Cannabis-induced psychosis: new entity?Makkos, Z. / Fejes, L. / Inczedy-Farkas, G. / Kassai-Farkas, A. / Lazary, J. et al. | 2010
- S451
-
P.3.a.040 Reasons for admission of psychotic patients to psychiatric emergency servicesFlorea, R. / Ho Quoc, H. / Courtet, P. H. et al. | 2010
- S454
-
P.3.b.005 Proton magnetic resonance spectroscopy measures predict a short-time symptomatic outcome in chronic schizophreniaSzulc, A. / Galinska, B. / Tarasow, E. / Kubas, B. / Konarzewska, B. / Poplawska, R. / Waszkiewicz, N. et al. | 2010
- S455
-
P.3.b.007 Epistasis between variations located in TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychoticsJun, T. / Pae, C. / Wang, H. R. / Serretti, A. et al. | 2010
- S456
-
P.3.b.009 Interaction analysis of apolipoprotein D and dopamine D2 receptor gene variants in schizophreniaAlmos, P. Z. / Horvath, S. / Juhasz, A. / Janka, Z. et al. | 2010
- S457
-
P.3.b.010 Examination of nociceptive behaviour and stress reactivity in susceptibility gene mutant models of schizophreniaOTuathaigh, C. / Walsh, J. / Tighe, O. / Karayiorgou, M. / Gogos, J. / Harvey, R. / Lai, D. / Waddington, J. L. et al. | 2010
- S458
-
P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndromeRisselada, A. / Vehof, J. / Bruggeman, R. / Wilffert, B. / Cohen, D. / Al Hadithy, A. F. / Arends, J. / Mulder, H. et al. | 2010
- S459
-
P.3.c.003 A randomized, controlled study to evaluate quetiapine fumarate in improving sleep quality of schizophreniaZhang, B. / Jia, F. J. / Zhou, P. et al. | 2010
- S460
-
P.3.c.005 Association of antipsychotic polypharmacy with health service cost - a Danish register-based cost-minimisation analysisBaandrup, L. / Sorensen, J. / Lublin, H. / Nordentoft, M. / Glenthoj, B. et al. | 2010
- S461
-
P.3.c.007 Compliance of outpatients using long acting antipsychotics with supportive outreaching: a matched case control studyVan Loon, H. / Vandenbroele, H. / De Bruyne, S. / Wybo, A. / Glorieux, M. / Dubois, V. / Gillain, B. / Peuskens, J. et al. | 2010
- S464
-
P.3.c.012 Paliperidone for the treatment of hyperactive delirium: short-term, open-label trialHan, C. / Yoon, H. K. / Ko, Y. H. et al. | 2010
- S465
-
P.3.c.014 The impact of the subjective response to antipsychotics on the course of illness in schizophrenic patientsMurawiec, S. et al. | 2010
- S466
-
P.3.c.016 Cognitive functions and dosage of antipsychotic drugs in Japanese schizophrenia patientsHori, H. / Yoshimura, R. / Katsuki, A. / Hayashi, K. / Sugita, A. / Nakano, W. / Nakamura, J. et al. | 2010
- S467
-
P.3.c.018 The characteristics of pharmacotherapy for inpatients with schizophrenia: a multicentre comparative study in AsiaNakano, W. / Yoshimura, R. / Yang, S. / Shinfuku, N. / Fujii, S. / Hoshuyama, T. / Sim, K. / Chong, M. / Tan, C. / Nakamura, J. et al. | 2010
- S468
-
P.3.c.019 Community treatment orders and psychotropic medication: baseline data analysis for a one year follow up study (N= 200)Patel, M. X. / Matonhodze, J. / Baig, M. / Gilleen, J. / Boydell, J. / Holloway, F. / Taylor, D. / Szmukler, G. / Lambert, T. J. / David, A. S. et al. | 2010
- S469
-
P.3.c.021 Intramuscular aripiprazole versus injectable haloperidol in treatment of acute psychotic agitationIstikoglou, C. / Vlavianou, A. / Foutsitzis, D. / Theodorakopoulos, G. / Polonifis, C. / Kanellos, P. / Vlissides, D. et al. | 2010
- S470
-
P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neurolepticsStrzelecki, D. / Rabe-Jablonska, J. et al. | 2010
- S471
-
P.3.c.024 Prevalence of and factors associated with nonadherence to antipsychotic drugs in patients with schizophreniaSuttajit, S. / Pilakanta, S. et al. | 2010
- S472
-
P.3.c.026 Risperidone depot versus zuclopenthixol depot for schizophrenia and schizophrenialike psychoses: real world outcomesParise, V. F. / Balletta, G. / Manna, G. et al. | 2010
- S473
-
P.3.c.028 Olanzapine in treatment of delusional disordersZivkovic, N. / Pavicevic, D. / Djokic, G. / Nenadovic, M. / Nenadovic, N. / Lekovic, J. et al. | 2010
- S474
-
P.3.c.029 A study to examine the efficacy and safety of amisulpride according to the different initial dosages in schizophreniaLee, J. H. / Lee, K. H. / Song, J. O. / Lee, S. J. / Lee, D. K. et al. | 2010
- S475
-
P.3.c.031 Risk of metabolic, cardiologic, and endocrinologic abnormalities in patients under long-term antipsychotic treatmentCerveri, G. / Mazzocchi, A. / Volonteri, L. S. / Mannussakis, C. / Mencacci, C. et al. | 2010
- S477
-
P.3.c.034 A 6-month naturalistic study of outcome in schizophrenic out-patients, treated with olanzapineKrzystanek, M. / Krupka-Matuszczyk, I. et al. | 2010
- S478
-
P.3.c.036 Antipsychotics prescribing pattern of patients with schizophrenia admitted to Korean general hospital: 2001 to 2008Choi, H. J. / Jung, S. H. / Kim, C. E. et al. | 2010
- S480
-
P.3.c.039 Effects of neuroleptic treatment on oxidative stress parameters in schizophrenia patientsIvanova, A. S. / Smirnova, L. P. / Krotenko, N. M. / Semke, A. V. et al. | 2010
- S481
-
P.3.c.041 A randomized, double-blind study of paliperidone palmitate and risperidone long-acting therapy in schizophreniaPandina, G. / Lane, R. / Gopal, S. / Gassmann-Mayer, C. / Hough, D. / Remmerie, B. / Simpson, G. et al. | 2010
- S483
-
P.3.c.044 Antipsychotic polypharmacy in a community psychiatric clinicWillis, C. / Naidoo, K. S. / Sawhney, P. et al. | 2010
- S484
-
P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophreniaSchmidt, M. / Janssens, L. / Kent, J. / Anghelescu, I. / Husken, G. / Sinha, V. / Mannaert, E. et al. | 2010
- S485
-
P.3.c.048 Treatment with antipsychotics in hospitalised patients with maniac episodeMahia, M. C. / Millares, M. V. / Santos, M. G. / Barbazan, C. A. et al. | 2010
- S486
-
P.3.c.050 Interaction between polymorphisms of oxidative enzymes and susceptibility to tardive dyskinesia in psychiatric patientsIvanova, S. A. / Al Hadithy, A. F. / Pechlivanoglou, P. / Semke, A. V. / Fedorenko, O. Y. / Levchuk, L. A. / Kornetova, E. G. / Brouwers, J. R. / Bruggeman, R. / Loonen, A. J. et al. | 2010
- S487
-
P.3.c.052 Overdose of paliperidone: a case reportOlivares, J. M. / Cinos, C. / Losada, C. P. / Gutierrez, F. J. / Lopez, M. et al. | 2010
- S488
-
P.3.c.053 Reasons for switching between antipsychotic drug treatments - the international antipsychotic drug substitution registryGalinska-Skok, B. / Paterakis, P. / Bubrovszky, M. / Thomas, P. / Perdriset, G. / Pani, L. et al. | 2010
- S489
-
P.3.c.055 Asenapine: short-term tolerability, safety, and pharmacokinetic profile in older patients with psychosisDubovsky, S. / Frobose, C. / Phiri, P. / Panagides, J. et al. | 2010
- S490
-
P.3.c.057 Which patients switch antipsychotic medication? Data from the international Antipsychotic Drug Substitution RegistryPaterakis, P. / Galinska-Skok, B. / Pani, L. / Bubrovszky, M. / Perdriset, G. / Thomas, P. et al. | 2010
- S491
-
P.3.c.059 Oxidative stress status in schizophrenic patients treated with typical versus atypical antipsychoticsPadurariu, M. / Dobrin, I. / Stefanescu, C. / Ciobica, A. / Dobrin, R. P. et al. | 2010
- S492
-
P.3.c.060 Aripiprazol in the treatment of catatonia -review of the literature and case reportsVoros, V. / Tenyi, T. et al. | 2010
- S493
-
P.3.c.062 The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophreniaBose, A. / Li, D. / Migliore, R. / Werner, P. / Nemeth, G. / Laszlovszky, I. et al. | 2010
- S494
-
P.3.c.064 Serum lipide profiles during antipsychotic treatment of schizophrenic subjectsSlavkovic, V. S. / Golubovic, S. T. / Gugleta, D. G. / Sibinovic, V. S. et al. | 2010
- S495
-
P.3.c.065 Comparison of multifactor dimensionality reduction (MDR) and neural network analysis: serotonergic system genes and antipsychotic responseDe Luca, V. / Souza, R. P. / Tiwari, A. / Meltzer, H. Y. / Potkin, S. G. / Volavka, J. / Lieberman, J. / Kennedy, J. L. / Serretti, A. et al. | 2010
- S496
-
P.3.c.067 One year study: efficacy of haloperidol versus risperidone in the treatment of schizoaffective disorderMladenovic, D. S. / Vukic, S. D. / Golubovic, B. / Ivezic, A. et al. | 2010
- S497
-
P.3.c.069 Dosage patterns - lessons learned from the e-STAR database in Czech RepublicCeskova, E. / Kopriva, J. et al. | 2010
- S498
-
P.3.d.002 Cognitive impairment in patients with psychotic disorder diagnosisBarbadillo, L. / Carton, J. / Ibarburu, E. / Martin, L. / Artola, M. et al. | 2010
- S499
-
P.3.d.004 Influence of aripiprazole, risperidone, and amisulpride on PPI and P50-suppression in healthy males with low levels of gatingCsomor, P. A. / Vollenweider, F. X. et al. | 2010
- S500
-
P.3.d.005 Activity of phosphodiesterase 10A inhibitors in a novel animal model of negative symptoms of schizophreniaLangen, B. / Zschaber, D. / Stange, H. / Hage, T. / Brandon, N. / Marquis, K. et al. | 2010
- S501
-
P.3.d.008 Massive creatin kinase and hepatic enzymes elevation due to quetiapine and valproic acid treatmentErdogan, S. / Celikel, F. C. et al. | 2010
- S502
-
P.3.d.010 Antipsychotic drugs induce dopamine type 2 receptor mediated suppression of neuronal firing in the rat nucleus incertusRajkumar, R. / Lee, M. N. / Dawe, G. S. et al. | 2010
- S504
-
P.3.d.013 Energetic metabolism, leptin are altered in rats submitted to chronic administration of olanzapineZugno, A. / Barcelos, M. / Fraga, D. / Oliveira, L. / Canever, L. / Luca, R. / Rezin, G. / Scaini, G. / Streck, E. / Quevedo, J. et al. | 2010
- S505
-
P.3.d.015 Treatment with memantine and imipramine induces changes in mitochondrial respiratory chain activity in the rat brainFraga, D. / Reus, G. / Stringari, R. / Rezin, G. / Daufenbach, J. / Streck, E. / Quevedo, J. / Zugno, A. et al. | 2010
- S507
-
P.3.e.001 Facial emotion recognition deficit in schizophrenia: a replication study in Korean subjectsLee, S. J. / Rim, H. D. / Park, Y. W. / Lee, J. J. / Jang, S. M. / Woo, J. M. / Jo, H. Y. / Lee, K. U. et al. | 2010
- S508
-
P.3.e.003 Effectiveness of olanzapine standard oral and orally disintegrating tablets in a 1-year European observational studyChartier, F. / Rouillon, F. / Lukasiewicz, M. / Kraemer, S. / Dyachkova, Y. et al. | 2010
- S509
-
P.3.e.005 Total blood cholesterol levels and serum creatine kinase activity in violent psychiatric inpatientsReznik, I. / Kertzman, S. / Grinspan, H. / Birger, M. / Shlapnikov, N. / Meltzer, H. Y. et al. | 2010
- S510
-
P.3.e.006 The utility of the MMPI-2 and PAI for discriminating the patients with schizophrenia and depression in KoreaPark, M. C. / Ko, Y. H. / Oh, S. W. / Park, J. I. et al. | 2010
- S511
-
P.3.e.008 Activation of the immune system with respect to cognitive functioning in schizophreniaFrydecka, D. / Beszlej, A. / Szewczuk-Boguslawska, M. / Zagdanska, M. / Karabon, L. / Pawlak, E. / Kiejna, A. et al. | 2010
- S512
-
P.3.e.010 Inhaled loxapine (AZ-004) rapidly improves acute agitation in patients with schizophrenia or bipolar disorderCassella, J. V. / Fishman, R. S. / Spyker, D. et al. | 2010
- S513
-
P.3.f.002 Quantifying rater drift in a sample of standardised rater training events: Is PANSS reliability maintained over time?DeFries, A. / Yavorsky, C. / Opler, M. / Ramadhar, L. / Ivanova, E. / Gordon, J. / Jovic, S. / Yang, L. et al. | 2010
- S514
-
P.3.f.003 Effect of clozapine on behavioural and cytokine profiles in rats with lipopolysaccharide and viral protein stimulationTejkalova, H. / Ruml, T. / Rumlova, M. / Klaschka, J. / Ruzickova, S. et al. | 2010
- S515
-
P.3.f.005 Different forms of risperidone and haloperidol in sexual dysfunction among schizophrenic male patientsSibinovic, V. / Tosic-Golubovic, S. / Gugleta, D. / Selimovic, G. / Zikic, O. et al. | 2010
- S517
-
P.3.f.008 The relationship between insight and psychosis in schizophrenic Romanian patientsCrisan, C. / Bondor, C. / Macrea, R. et al. | 2010
- S518
-
P.3.f.010 Continuous perfomance test dysfunction in delusional disorder: an fMRI investigationAkyuz, F. / Oflaz, S. / Hamamci, A. / Firat, Z. / Cihangiroglu, M. et al. | 2010
- S519
-
P.3.f.012 Psychoneuroimmune interactions in schizophreniaLobacheva, O. / Vetlugina, T. P. et al. | 2010
- S520
-
P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapseFineberg, N. A. / Stein, D. J. / Legault, M. / Marteau, F. / Hollander, E. et al. | 2010
- S521
-
P.4.a.003 Are tics an essential symptom of the obsessive-compulsive syndrome?Hranov, G. / Fineberg, N. A. et al. | 2010
- S522
-
P.4.a.004 A comparison of different types of obsessions due to brain damageMargaryan, S. et al. | 2010
- S523
-
P.4.a.006 Differences in duration of untreated illness in patients with anxiety disordersDellOsso, B. / Buoli, M. / Lietti, L. / Oldani, L. / Camuri, G. / Benatti, B. / Catenacci, E. / Bressi, C. / Altamura, A. C. et al. | 2010
- S525
-
P.4.a.009 Efficacy of pregabalin in generalised social anxiety disorder: results of a placebo-controlled, fixed-dose studyFeltner, D. / Bielski, R. / Liu-Dumaw, M. et al. | 2010
- S526
-
P.4.a.011 Neuropsychological effects of nucleus accumbens deep brain stimulation surgery for obsessive-compulsive disorderMantione, M. / Nieman, D. / Schuurman, R. / Denys, D. et al. | 2010
- S527
-
P.4.a.013 Critical elements of cognitive behavioural therapy (CBT) for panic disorder with agoraphobia: a preliminary examination of the influence of exposureGloster, A. T. / Hofler, M. / Wittchen, H. U. et al. | 2010
- S528
-
P.4.a.014 Alcohol use and drinking motivation in posttraumatic stress disorder patients: a case-control studySo, H. / Jung, H. / Choi, J. / Kim, T. / Chung, M. / Lee, S. et al. | 2010
- S529
-
P.4.a.016 Occurrence of traumatic brain injuries in patients with chronic posttraumatic stress disorderSimonovic, M. / Radisavljevic, M. / Grbesa, G. et al. | 2010
- S530
-
P.4.b.002 Effects of novel 3,4-dimethoxyphenyl-ethylamine derivates on anxiety-like behaviour: a pilot studyFedotova, J. / Barishpolec, V. / Markarov, G. et al. | 2010
- S531
-
P.4.b.004 Investigation of effects of fluoxetine on unpredictable chronic mild stress-induced changes of brain tissue by Fourier transform mid-infrared spectroscopyTurker, S. / Mutlu, O. / Komsuoglu, I. / Gumuslu, E. / Yildiz, F. / Erden, F. et al. | 2010
- S534
-
P.4.b.009 Posttraumatic stress disorder and inflammationMkrtchyan, G. / Hovhannisyan, L. / Boyajyan, A. / Tadevosyan, M. / Kalashyan, A. / Sukiasian, S. et al. | 2010
- S535
-
P.4.b.0111 The aversive state induced by periaqueductal gray stimulation modulates the reconsolidation of a fear memoryMochny, C. / Kincheski, G. C. / Molina, V. A. / Carobrez, A. P. et al. | 2010
- S536
-
P.4.b.013 Effect of diazepam on conditioned fear evoked by an ethological model of panic involving prey versus predator encountersCastiblanco-Urbina, M. A. / Twardowschy, A. / Uribe-Marino, A. / Francisco, A. / Coimbra, N. C. et al. | 2010
- S537
-
P.4.b.014 Effects of diazepam on fear behaviours evoked by a model of panic involving prey versus predator confrontationsFrancisco, A. / Castiblanco-Urbina, M. A. / Twardowschy, A. / Uribe-Marino, A. / Coimbra, N. C. et al. | 2010
- S538
-
P.4.b.016 Ventromedial prefrontal cortex activity is required for anxiety expression: distinct neurochemical mechanisms evidenceStern, C. A. / Do-Monte, F. H. / Gazarini, L. / Carobrez, A. P. / Bertoglio, L. J. et al. | 2010
- S539
-
P.4.b.018 Examining face and construct validity of a non-invasive model of panic disorder in lister-hooded ratsPrinssen, E. / Nicolas, L. B. / Lopez, C. L. / Jacobson, L. H. / Gatti, S. / Grundschober, C. / Klein, S. et al. | 2010
- S541
-
P.4.c.001 Efficacy of repetitive transcranial magnetic stimulations in the management of obsessive compulsive disorderEL-Sawy, H. / Badawy, A. D. / Abdelhay, M. et al. | 2010
- S542
-
P.4.c.003 Ondansetron augmentation in resistant OCD: relapse in symptoms following discontinuation of ondansetronPallanti, S. / Antonini, S. / Bernardi, S. / Hollander, E. et al. | 2010
- S544
-
P.4.c.006 Day 3&7 jitteriness symptoms predict poor 6 week outcome in SSRI treatment and correlate with day 7 nocturnal activityChristmas, D. / Davies, S. J. / Hince, D. A. / Williams, J. / Schroeder, K. / Nutt, D. J. et al. | 2010
- S545
-
P.4.d.002 Electroencephalographic activity defines the temporal-window for pentylenetetrazole role as an unconditioned stimulusCavalli, J. / Hoeller, A. A. / Duzzioni, M. / De-Lima, T. C. / Bertoglio, L. J. / Carobrez, A. P. et al. | 2010
- S546
-
P.4.e.001 Lost productivity time among workers with panic disorder and the improvement after 12 weeks of pharmacotherapyWoo, J. / Kim, W. et al. | 2010
- S547
-
P.4.e.003 Clomipramine and quetiapine augmentation for obsessive compulsive disorder compared to sustained fluoxetine treatmentDiniz, J. B. / Pereira, C. A. / Miguel, E. C. / Shavitt, R. G. et al. | 2010
- S548
-
P.4.e.005 Obsessionality in the general population and in psychiatric disordersBlom, R. M. / de Bruijn, C. / de Graaf, R. / ten Have, M. / Denys, D. et al. | 2010
- S550
-
P.5.a.002 Accessing treatment and services for people with dementia: a pilot studySpencer, R. / Curran, S. / Roberts, N. / Minogue, V. / Shewan, J. / Wattis, J. et al. | 2010
- S553
-
P.5.a.007 Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinsons diseaseVasile, D. / Vasiliu, O. / Vasile, M. L. / Terpan, M. / Grigorescu, G. / Bogdan, V. / Mangalagiu, A. / Petrescu, M. B. / Ojog, D. et al. | 2010
- S554
-
P.5.a.009 Relationship between subjective memory complaints and cognitive function in the elderlyLim, K. Y. / Chang, K. J. / Lee, K. S. / Kim, H. J. / Cheong, H. K. / Oh, B. H. / Hong, C. H. et al. | 2010
- S556
-
P.5.a.012 Effects of memantine on global clinical status in patients with moderate Alzheimers diseaseGraham, S. M. / Hofbauer, R. K. / Hendrix, S. / Tocco, M. / Perhach, J. L. et al. | 2010
- S557
-
P.5.a.014 Functional communication in patients with moderate Alzheimers disease treated with memantineGraham, S. / Tocco, M. / Hendrix, S. / Hofbauer, R. K. / Perhach, J. L. et al. | 2010
- S558
-
P.5.a.016 Automated classification of MR images for recognising Alzheimers disease in living patientsSimsek, F. / Polat, F. / Demirel, O. / Kitis, O. / Haznedaroglu, D. / Eker, C. / Kumral, E. / Gonul, A. S. et al. | 2010
- S560
-
P.5.b.001 Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controlsOssenkoppele, R. / Tolboom, N. / van der Flier, W. M. / Yaqub, M. / Windhorst, A. D. / Boellaard, R. / Barkhof, F. / Lammertsma, A. A. / Scheltens, P. / van Berckel, B. N. et al. | 2010
- S561
-
P.5.b.003 Psychopharmacological intervention in cognitive impairment comorbid with medical and/or psychiatric pathologyLedo, A. I. / Sanchez, I. / Lopez, I. / Soto, A. / Marques, P. et al. | 2010
- S562
-
P.5.c.002 Eating disorders and deep brain stimulation of the subthalamic nucleus in Parkinsons DiseaseChereau, I. / De Chazeron, I. / Rieu, I. / Derost, P. p. / Lemaire, J. j. / Llorca, P. m. / Durif, F. et al. | 2010
- S563
-
P.5.d.001 1-Benzyl-1,2,3,4-tetrahydroisoquinoline inhibits L-DOPA-induced increase of dopamine metabolism in rat brainWasik, A. / Kajta, M. / Romanska, I. / Antkiewicz-Michaluk, L. et al. | 2010
- S564
-
P.5.d.002 The protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on rotenone-induced irregularities in rat brainAntkiewicz-Michaluk, L. / Wasik, A. / Romanska, I. / Boksa, J. / Michaluk, J. et al. | 2010
- S565
-
P.5.d.004 Neuroprotective effect of cerebrolysin and erythropoietin versus haloperidol in an Alzheimers disease - animal modelMogoanta, L. / Marinescu, D. / Udristoiu, T. / Udristoiu, I. / Pirici, D. et al. | 2010
- S566
-
P.5.d.006 Pro-and antioxidant mechanisms in patients in different clinical forms of multiple sclerosis current in treatmentSmirnova, L. / Krotenko, N. / Alifirova, V. et al. | 2010
- S567
-
P.5.e.001 Patient characteristics for misdiagnosed delirium at psychiatric consultation in a university hospitalYun, K. W. / Choi, J. W. / Park, H. S. / Ryoo, J. H. / Kim, Y. C. / Lim, W. J. / Kim, E. J. / Kim, S. I. et al. | 2010